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ABSTRACT 
This case study was conducted to pretest the burden of disease methodology in 
Sudan settings. It aimed at measuring the burden of selected diseases and injuries in 
Sudan in 2002, using Disability Adjusted Life Years (DALYs). The diseases were Malaria, 
Measles, Protein energy malnutrition, Low birth weight, Maternal hemorrhage, Diabetes 
Mellitus and Road traffic accidents. It also aimed to analyze the sensitivity of the burden 
to changes in the weights given to different disabilities. 
A search for local studies and reports providing epidemiological data on these 
diseases was conducted. Preliminary epidemiological estimates were developed from the 
data. The estimates included mortality rates, incidence rates, prevalence proportions, case 
fatality hazards, remission hazards, average duration and relative risk of mortality. The 
preliminary estimates were entered into disease modeling computer software; DISMOD. 
This produced internally consistent mortality and incidence rates that were used to 
calculate DALYs for each disease.  
For both males and females, low birth weight accounted for the highest burden 
followed by protein energy malnutrition, malaria, measles, Diabetes Mellitus and road 
traffic accidents, with maternal hemorrhage preceding the latter in females. The rank 
order of the diseases varied in the different age groups. The change in disease burden 
when using a different set of disability weights was the greatest in diseases with a high 
disability burden and in those were the difference between the disability weights given to 
a condition is large. The validity of disease burden estimates was reduced by uncertainties 
arising from different sources. The study revealed deficiencies in epidemiological data of 
the diseases under study. Further revisions and improvement of the methods used, with 
refinement of the final estimates of incidence and mortality of the diseases under study, 
were recommended. It is also important to conduct a full analysis of all disease and injury 
burden in Sudan. More reliable epidemiological data should be provided by improving 
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the vital registration system, and conduction of population based longitudinal studies and 
national surveys.   
 اﻟﺨﻼﺻﺔ 
IV 
 اﻟﺨﻼﺻﺔ
أﺟﺮﻳѧﺖ هѧѧﺬﻩ اﻟﺪراﺳѧѧﺔ ﻹﺧﺘﺒѧѧﺎر ﻣﻨﻬﺠﻴѧﺔ ﻗﻴѧѧﺎس ﻋѧѧﺐء اﻷﻣѧѧﺮاض ﻓѧѧﻲ ﻇѧѧﺮوف اﻟѧѧﺴﻮدان، ﺑﺎﺳѧѧﺘﺨﺪام 
 ﻟﻤﺠﻤﻮﻋѧﺔ 2002هﺪﻓﺖ اﻟﺪراﺳﺔ ﻟﺤﺴﺎب هﺬا اﻟﻤﻮﺷѧﺮ ﻓѧﻲ اﻟѧﺴﻮدان ﻟﻠﻌѧﺎم ".اﻟﺴﻨﻮات اﻟﻤﻔﻘﻮدة اﻟﻤﻌﺪﻟﺔ ﻟﻺﻋﺎﻗﺔ"ﻣﺆﺷﺮ 
 ﻧﻘѧﺺ اﻟﻄﺎﻗѧﺔ و اﻟﺒѧﺮوﺗﻴﻦ، اﻟﻤﻼرﻳѧﺎ، اﻟﺤѧﺼﺒﺔ، ﺳѧﻮء اﻟﺘﻐﺬﻳѧﺔ ﺑѧﺴﺒﺐ : ﻣﺨﺘﺎرة ﻣѧﻦ اﻷﻣѧﺮاض واﻹﺻѧﺎﺑﺎت ﺗﺘﻜѧﻮن ﻣѧﻦ 
هѧѧﺪﻓﺖ اﻟﺪراﺳѧѧﺔ أﻳѧѧﻀًﺎ ﻟﺘﺤﻠﻴѧѧﻞ ﻣѧѧﺪى . ﻧﻘѧѧﺺ وزن اﻟﻤﻮاﻟﻴѧѧﺪ، ﻧﺰﻳѧѧﻒ اﻷﻣﻬѧѧﺎت، اﻟѧѧﺴﻜﺮي وإﺻѧѧﺎﺑﺎت ﺣѧѧﻮادث اﻟﻤѧѧﺮور 
  .ﺣﺴﺎﺳﻴﺔ اﻟﻌﺐء اﻟﻤﻘﺎس ﻟﺘﻐﻴﺮ اﻷوزان اﻟﻤﻌﻄﺎة ﻷﻧﻮاع اﻹﻋﺎﻗﺔ اﻟﻤﺨﺘﻠﻔﺔ
ﺬﻩ ﺗѧѧﻢ اﻟﺒﺤѧѧﺚ ﻋѧѧﻦ اﻟﺪراﺳѧѧﺎت واﻟﺘﻘѧѧﺎرﻳﺮ اﻟﺘѧѧﻰ ﺗﺤﺘѧѧﻮي ﻋﻠѧѧﻰ ﺑﻴﺎﻧѧѧﺎت وﻣﻌﻠﻮﻣѧѧﺎت وﺑﺎﺋﻴѧѧﺔ ﺗﺨѧѧﺺ هѧѧ 
اﻷﻣﺮاض ﻓﻲ اﻟﺴﻮدان، ﺛﻢ ﺗﻢ ﺗﻄﻮﻳﺮ ﻣﺆﺷﺮات وﺑﺎﺋﻴﺔ أوﻟﻴﺔ ﻟﻜﻞ ﻣѧﺮض واﻹﻋﺎﻗѧﺔ اﻟﻨﺎﺗﺠѧﺔ ﻣﻨѧﻪ، ﻣѧﻦ اﻟﻤﻌﻠﻮﻣѧﺎت اﻟﺘѧﻲ 
ﺿѧﻤﺖ هѧﺬﻩ اﻟﻤﺆﺷѧﺮات ﻣﻌѧﺪل اﻟﻮﻓѧﺎة، ﻣﻌѧﺪل اﻹﺻѧﺎﺑﺔ، ﻣﻌѧﺪل اﻹﻧﺘѧﺸﺎر، ﻣﻌѧﺪل اﻹﻣﺎﺗѧﺔ، ﻣﻌѧﺪل . ﺗѧﻢ اﻟﺤѧﺼﻮل ﻋﻠﻴﻬѧﺎ
ﺮات ﺑﻮاﺳѧﻄﺔ اﻟﺤﺎﺳѧﻮب وﺑﺎﺳѧﺘﺨﺪام ﺑﺮﻧѧﺎﻣﺞ ﻋѧﺪﻟﺖ هѧﺬﻩ اﻟﻤﺆﺷѧ . اﻟﺘﺤﺴﻦ، ﻣﺘﻮﺳﻂ ﻣﺪة اﻟﻤﺮض وﺧﻄﺮ اﻟﻮﻓѧﺎة اﻟﻨѧﺴﺒﻲ 
 ﻟﺘﺘﻨﺎﺳѧﺐ داﺧﻠﻴѧًﺎ ﻣѧﻊ ﺑﻌѧﻀﻬﺎ اﻟѧﺒﻌﺾ، ﺛѧﻢ اﺳѧﺘﺨﺪم ﻣﻌѧﺪﻟﻲ اﻟﻮﻓѧﺎة واﻹﺻѧﺎﺑﺔ اﻟﻨѧﺎﺗﺠﻴﻦ ﻟﺤѧﺴﺎب اﻟѧﺴﻨﻮات DOMSID
  .اﻟﻤﻔﻘﻮدة اﻟﻤﻌﺪﻟﺔ ﻟﻺﻋﺎﻗﺔ ﻟﻜﻞ ﻣﺮض
أﻇﻬѧﺮت اﻟﻨﺘѧﺎﺋﺞ أﻧѧﻪ ﻋﻨѧﺪ اﻟѧﺬآﻮر واﻹﻧѧﺎث، آﺎﻧѧﺖ أآﺜѧﺮ أﻣѧﺮاض اﻟﻤﺠﻤﻮﻋѧﺔ ﻋﺒﺌѧًﺎ هѧﻮ ﻧﻘѧﺺ وزن 
ًا إﺻѧﺎﺑﺎت ﺣѧﻮادث اﻟﻤѧﺮور، ﻣѧﻊ ﺗﻘѧﺪم ﻧﺰﻳѧﻒ رﻳﺎ، ﺛﻢ اﻟﺤѧﺼﺒﺔ، ﺛѧﻢ اﻟѧﺴﻜﺮي وأﺧﻴѧﺮ ﻪ ﺳﻮء اﻟﺘﻐﺬﻳﺔ، ﺛﻢ اﻟﻤﻼ اﻟﻤﻮاﻟﻴﺪ ﻳﻠﻴ 
ﻋﻨѧﺪ ﺗﻐﻴﻴѧﺮ . إﺧﺘﻠﻒ ﺗﺮﺗﻴﺐ اﻹﻣﺮاض ﺣﺴﺐ اﻟﻌﺐء ﺑﺈﺧﺘﻼف اﻟﻤﺠﻤﻮﻋﺎت اﻟﻌﻤﺮﻳﺔ . اﻷﻣﻬﺎت ﻋﻠﻰ اﻷﺧﻴﺮ ﻋﻨﺪ اﻹﻧﺎث 
اض اﻟﺘﻲ ﺷﻜﻠﺖ اﻹﻋﺎﻗﺔ ﺟѧﺰء آﺒﻴѧﺮ ﻣﻨѧﻪ، اﻹوزان اﻟﻤﻌﻄﺎة ﻟﻜﻞ ﻧﻮع ﻣﻦ اﻹﻋﺎﻗﺔ، ﻇﻬﺮ اﻟﺘﺄﺛﻴﺮ اﻷآﺒﺮ ﻓﻲ ﻋﺐء اﻹﻣﺮ 
  .  ﺑﺎﻹﺿﺎﻓﺔ اﻟﻰ اﻷﻣﺮاض اﻟﺘﻲ إﺧﺘﻠﻔﺖ ﻓﻴﻬﺎ اﻷوزان اﻟﻤﺴﺘﺨﺪﻣﺔ إﺧﺘﻼﻓًﺎ آﺒﻴﺮًا
 اﻷﻣѧѧﺮاض  ﺑﻌѧѧﺾ ﺑﺎﻟѧѧﺴﻮدان ﻓѧѧﻲ اﻟﻤﻌﻠﻮﻣѧѧﺎت اﻟﺨﺎﺻѧѧﺔ ﺑﻮﺑﺎﺋﻴѧѧﺎت ﻧﻘѧѧﺺأﻇﻬѧѧﺮت اﻟﺪراﺳѧѧﺔ وﺟѧѧﻮد 
ﺔ ﺑﺘﺤﺴﻴﻦ ﻧﻈѧﺎم اﻟﻤﻌﻠﻮﻣѧﺎت اﻟﺤﻴﻮﻳѧﺔ اﻟﻤﺪروﺳﺔ ، ﻓﺘﻀﻤﻨﺖ ﺗﻮﺻﻴﺎت اﻟﺪراﺳﺔ ﺗﻮﻓﻴﺮاﻟﺒﻴﺎﻧﺎت اﻟﻮﺑﺎﺋﻴﺔ ذات اﻟﺠﻮدة اﻟﻌﺎﻟﻴ 
وإﺟѧѧﺮاء اﻟﺒﺤѧѧﻮث واﻟﻤѧѧﺴﻮﺣﺎت اﻟﻘﻮﻣﻴѧѧﺔ، ﻣﺮاﺟﻌѧѧﺔ وﺗﻄѧѧﻮﻳﺮ اﻟﻄﺮاﺋѧѧﻖ اﻟﻤѧѧﺴﺘﺨﺪﻣﺔ ﻓѧѧﻲ ﺗﺤѧѧﻀﻴﺮ اﻟﻤﺆﺷѧѧﺮات اﻷوﻟﻴѧѧﺔ 
وﺗﻌﺪﻳﻠﻬﺎ، ﺗﻨﻘﻴﺢ اﻟﻤﻮﺷﺮات اﻟﻤﻌﺪﻟﺔ اﻟﻨﺎﺗﺠﺔ ﻣﻦ ﺑﺮﻧﺎﻣﺞ اﻟﺤﺎﺳﻮب، وﻗﻴﺎس ﻋﺐء ﺟﻤﻴﻊ اﻷﻣѧﺮاض ﺑﺎﻟѧﺴﻮدان ﺑﺈﺳѧﺘﺨﺪام 
  .  اﻟﻤﻨﻬﺠﻴﺔ اﻟﻤﺨﺘﺒﺮة
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INTRODUCTION 
The burden of disease is important information that is required for assessing the 
health needs of the population, setting of priorities, allocation of scarce resources and 
monitoring and evaluation of health services, activities and programs (1). Traditionally it 
was expressed as rates of occurrence (incidence and prevalence rates), mortality and 
disability. The problem with this approach is that it hinders comparison between diseases 
due to the different estimates used in expressing the burden of different diseases. Large 
numbers of statistics are encountered when comparisons are made between populations 
or across time (2). Disability tends to be overlooked due to the traditional influence of 
mortality, so that disabling diseases are given less attention than killing diseases. 
Moreover, this approach describes the current burden only with no implications of future 
health status. 
The Global burden of Disease study (GBD) (3) quantified the global burden of 
diseases, injuries and risk factors, using an approach that combined information on 
mortality and morbidity. The estimate designed and calculated was the Disability 
Adjusted Life Years (DALY). This summarizes mortality and morbidity estimates in one 
figure, facilitating comparisons and providing comprehensive information on the burden 
of disease. It describes both the current and future losses from the health of populations. 
It also provides a link to cost effectiveness analysis of health related interventions. 
National burden of disease studies were conducted in many countries and they were 
useful in guiding health sector reform and priority setting in these countries (2).   
There is no previous experience with the application of burden of disease analysis in 
Sudan. Although guidelines for planning and conducting national burden of disease 
studies exist, the methods proposed are general and need local adaptation (2). In the 
GBD 2000 (4), country specific estimates of disease burden have been derived by 
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imputation from regional estimates for some diseases, and directly from country specific 
data for other diseases. Locally developed and revised methods that utilize local data and 
research results were not developed. Developing local models is important because they 
will provide more approximate estimates. Burden of disease methods utilize secondary 
data. The availability of the data needed for burden of disease analysis has not been 
explored before in Sudan. Health state valuations are incorporated into the calculation of 
DALYs. Several sets have been developed and decision has to be made as to which set 
should be used for Sudan. To make this decision it is important to know first how 
changing health state valuations affects disease burden. 
This study aims to synthesize the results of local surveys and research conducted in 
a group of selected conditions into DALY estimates, using locally adapted and revised 
methods. The selected conditions are: malaria, measles, protein energy malnutrition, low 
birth weight, maternal hemorrhage, diabetes mellitus and road traffic accidents. This 
group was selected because each disease represents a broad category of diseases as 
classified in the GBD. These categories are: communicable diseases, maternal conditions, 
perinatal conditions, nutritional deficiencies, non communicable diseases and injuries. 
 The study will provide experience with all steps involved in measuring the burden 
of different types of diseases, using DALYs.  The study will identify different constraints 
that may be faced during all stages of burden analysis. The sensitivity of the results to the 
types of health state valuations will be used by the researchers, to decide which type 
should be used for disease burden measurement in Sudan. The study will also provide 
initial estimates of the burden of some selected diseases regarded as public health 
priorities, in a new approach that combines information on mortality and non–fatal 
health outcomes. Moreover, by examining the different data sources available for these 
conditions, gaps in information will be identified and future research will be directed 
towards filling them. 
Because Sudan is a low income country, the results are expected to show a 
significant burden of mortality and disability due to communicable, perinatal, maternal 
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and nutritional conditions. Difficulties in obtaining data and synthesizing them into final 
estimates are also expected. 
 Objectives 
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OBJECTIVES 
GENERAL OBJECTIVE 
To measure the burden of selected diseases and injuries in Sudan for the year 2002 in 
order to pretest burden of disease methodology in local settings.  
SPECIFIC OBJECTIVES 
1. To develop internally consistent estimates of national incidence and mortality rates 
for the following conditions: 
a. Malaria 
b. Measles 
c. Protein energy malnutrition 
d. Low birth weight 
e. Maternal haemorrhage 
f. Diabetes mellitus 
g. Road traffic accidents 
2. To calculate age and sex specific Disability Adjusted Life Years for the conditions 
under study. 
3. To analyze the sensitivity of the calculated burden to the set of disability weights 
used. 
4. To develop experience in the application of the DALY approach in Sudan  
5. To identify data gaps and constraints in conducting national burden of disease 
studies in Sudan. 
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LITERATURE REVIEW 
MEASURING POPULATION HEALTH 
The defining goal of health systems is to improve health. Measuring population health 
is therefore an important part of assessing health system performance. Population health 
is measured at 2 levels: The average level of health and the distribution of health 
inequalities in the population. Population health should reflect individual’s health 
throughout life and should consider non fatal health outcomes together with mortality 
(5). Moreover, scarcity of resources makes it difficult to meet all the health needs of the 
population. Effective and equitable resource allocation calls for objective measurement of 
the burden of disease in populations.    
SUMMARY MEASURES OF POPULATION HEALTH 
The burden of diseases in a population depends on the diseases frequency and 
severity. Incidence density, cumulative incidence and prevalence are measures of disease 
frequency. Severity is measured by premature mortality (death before expectation of life 
in the absence of the disease) and morbidity (impairments, disability and handicaps 
resulting from the disease) (6). 
Summary measures of population health are composite health indicators that combine 
information on mortality and non fatal health outcomes (morbidity) in a single number 
and therefore summarize the average level of population health. (1). Over the past 20 
years composite indicators have been developed for the main reason of enabling evidence 
based resource allocation and health policy formulation (6). 
All summary measures use the unit of time to express disease burden. Their 
calculation requires information about age specific mortality, the epidemiology of non 
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fatal health outcomes and the values given to different health states in relation to ideal 
health or death. They use readily available information from different sources.  
MERITS OF SUMMARY MEASURES OF POPULATION HEALTH OVER TRADITIONAL 
INDICATORS 
1. They combine mortality with morbidity and therefore consider diseases that 
have no great mortality impact but considerable morbidity. (1) 
2. They use time as a unit of measurement and this was identified as the best 
approach to measuring the burden of disease.(3) 
3. They are easy to understand and convey to policy makers.(2) 
USES OF SUMMARY MEASURES OF POPULATION HEALTH 
1. Comparing the health of different populations. This allows focusing on 
populations with the poor health system performance. 
2. Monitoring changes in the health of a given population. 
3. Identifying and quantifying overall health inequalities between populations. 
4. Providing attention to the effects of non fatal health outcomes on the 
health of the population. 
5. Informing debates on priorities for health service delivery and planning thus 
enabling evidence based resource allocation. 
6. Short-listing priorities for research and development. 
7. Analysing the benefits of a health intervention in cost effectiveness 
analyses. 
8. Enriching curricula for professional training in public health (1).  
TYPES OF SUMMARY MEASURES 
Summary measures are divided into health expectancies and health gaps: 
Health expectancies 
These are life expectancies that give lower weights for years lived in health 
states worse than full health 
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Examples: Active life expectancy (ALE), Disability Free Life Expectancy 
(DFLE), Disability adjusted life expectancy (DALE), Years of healthy life (YHL), 
quality adjusted life expectancy (QALY), dementia free life expectancy, health 
capital, and cause deleted life expectancy. 
They are based on life tables and therefore are age adjusted and do not depend 
on any particular age structure. 
Health gaps 
These quantify the difference between the actual health of a population and 
some stated norm for population health. They are mortality gaps that take into 
account time lived in a state worse than ideal health. Examples include: DALYs, 
HeaLYs. 
Health gaps are expressed in absolute terms and therefore are age dependant 
and are affected by the age structure of the population in which they are applied. 
Figure I shows a survivorship curve of a hypothetical population. 
Area A+B is the life expectancy at birth. 
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Health expectancy = A + f (B) where f is a function representing weights or values 
given to time lived in a state worse than ideal health. These weights vary from 0 to 1 with 
1 being ideal health. 
Health gap = C + g (B) where g is a function representing weights given to time lived 
in a suboptimal health state, with 1 being equivalent to death. 
Summary measures also vary according to the method of health state valuation. Some 
like DFLE use dichotomous valuations that assign a value of 0 to a health state below an 
arbitrary level and a value of 1 to health states above it. Others like the DALE and 
DALYs use polychotomous or continuous valuations with a range of weights from 0 
to 1. These vary further according to: 
1. The persons assigning the values: patients, health care providers or relatives 
of patients. 
2. Method of valuation 
3. The description of the health states including the domains of health used in 
the description. 
Figure I: The survivorship curve of a hypothetical population 
 
Source: A critical examination of summary measures of population health (1). 
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4. The range of health states valued at the same time. 
5. The deliberative process by which the valuation is made (1).  
RELATING SUMMARY MEASURES TO CAUSES OF BURDEN 
For SMPH to be useful, the relative magnitude of different health problems (diseases, 
injuries and risk factors) should be identified. This causal attribution is usually done by 2 
methods: 
Categorical attribution: attribution of burden to single cause categories that are 
mutually exclusive. It is suitable only for health gaps and is used for diseases and injures 
only. 
Counterfactual analysis: this compares the current and future levels of SMPH with 
levels expected under a hypothetical scenario (2). It can be used for health gaps but is 
more useful for health expectancies and for health gaps measuring the burden of risk 
factors. 
SMPH are useful tools that assist in decision making but they should be used with 
caution due to the uncertainty associated with them. They use readily available data from 
different source and uncertainty comes from problems of reliability and validity of these 
data (6). Users of these indicators should be aware of these uncertainties. 
DISABILITY ADJUSTED LIFE YEARS 
DALY is a health gap measure that combines mortality and morbidity. It was 
developed for the GBD, a study that was started by the WHO and Harvard School of 
Public Health to measure the burden of disease and injury in the world human 
population (2) 
DALY is a widely used indicator that influences policy debates. Because of this its 
design incorporated values that might seem reasonable for most of the society. These 
values are: 
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1. The value of one year lost by death or disease at any age is the same for all 
populations of the world irrespective of race, socioeconomic status and other 
factors. 
2. The only variables that should be considered in calculating the burden of 
disease are age and sex. According to these variables mortality and morbidity 
components of DALYs may be calculated differently. 
3. DALYs are used to quantify proximal biomedical factors that affect health i.e. 
disease and injuries as well as distal factors such as environmental and 
socioeconomic factors (3).  
CALCULATION OF DALYS 
DALYs are usually disaggregated by age and sex and can be calculated by 
geographical region. Being incidence based they are calculated for a reference year. This is 
usually the most recent data rich year such as a census year (2). The GBD measured the 
global burden of disease for the years 1990 and 2000 and ever since has been doing yearly 
revision and update of the estimates (4,7). GBD 1990 has also projected the burden of 
disease to the year 2020 (8) and quantified the burden attributable to selected risk factors 
(9). The study initially used 5 age groups for the burden of disease in 1990. For 
subsequent revisions 8 age groups were used. In 1990, the World Bank divisions of the 
world into 6 regions were used to report the result. These were subsequently divided to 
form 14 regions, based on levels of child (less than 5 years) and adult (15 - 59 years) 
mortality. Further subdivisions were made to form 17 subregions that were rearranged to 
the 14 regions used for reporting. 
Five mortality strata were defined in terms of quintiles of the distribution of 5q0 and 
45q15 (both sexes combined) as shown in Table 2. Adult mortality 45q15 was regressed on 
5q0 and the regression line used to divide countries with high child mortality into high 
adult mortality (stratum D) and very high adult mortality (stratum E). Stratum E includes 
the countries in sub-Saharan Africa where HIV/AIDS has had a very substantial impact 
(7). 
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Table 1: Definitions of mortality strata used to define WHO subregions for the GBD 2000 
Mortality 
stratum Child mortality Definition 
Adult 
mortality 
A Very low child mortality (1st quintile of 5q0) 5
q0  < 0.0122 
Low adult 
mortality 
B Low child mortality (2
nd 
and 3rd quintile of 5q0) 
0.0122< 5q0  < 
0.062 
Low adult 
mortality 
C Low child mortality (2
nd 
and 3rd quintile of 5q0) 
0.0122< 5q0  < 
0.062 
High adult 
mortality 
D High child mortality (4
th 
and 5th quintile of 5q0) 
0.062< 5q0 
High adult 
mortality 
E High child mortality (4
th 
and 5th quintile of 5q0) 
0.062< 5q0 
Very high 
adult mortality 
 Source: GBD 2000 (7). 
A demographic input is required for calculation of DALYs: 
1. Total midyear population by age and sex for the reference year, obtained from 
census and projections. This is needed for calculating numbers from rates. 
2. Total mortality by age and sex for the reference year. This serves as an envelope 
for validating cause of death data. The sum of cause specific number of deaths for 
each age and sex group should equal the total mortality for that group. It can be 
obtained from the following sources: 
i. Vital registration: to be useful death registration completeness should 
ideally be not less than 95% and a minimum cut off point of 80%. 
Demographic techniques are used to check completeness of death 
registration and correct for incompleteness. 
ii. Sample registration systems: these collect vital events data for a 
representative sample of the population. 
iii. Household surveys: provide child and infant mortality data using 
direct methods and adult mortality using indirect methods (2). 
iv. Demographic techniques: these include the WHO modified Brass 
Logit method used for countries where vital registration is too poor 
to adjust and there is no survey mortality data (4). Most surveys 
report on child mortality. This was used to predict adult mortality 
and both were used in the Logit method to construct a full life table 
(10).  This method was used in the GBD to estimate the all cause 
mortality rates by age and sex and construct a life table for countries 
with no source of mortality data (11). 
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DALY has 2 components: 
Mortality component:  
This is the years of life lost (YLL). It is calculated from: 
1. Cause specific mortality rates by age and sex 
2. Life expectancy for each age sex group. 
Cause of  death data 
Cause of death data is also used to validate epidemiological estimates or calculate 
incidence when this is unknown. 
Sources of  data 
1. Vital registration systems: 
This is the gold standard if it records at least 70% and ideally 95% of all 
deaths. The deaths should be cause specific with the cause medically certified (by 
a medical practitioner). 
2. Sample registration systems: data on causes of death use medical 
certification as well as verbal autopsies (identifying the cause of death from history 
provided by individuals’ family supplemented by medical records where possible). 
These systems were the source of mortality data for India in the GBD. 
3. Household surveys: these may include child and adult mortality modules 
with verbal autopsies.  
4. Population surveillance systems: population laboratories that provide vital 
registration events for a small population. 
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5. Epidemiological estimates: 
Incidence, remission and case fatality can be used to estimate mortality. 
Epidemiological estimates as well as epidemiological surveys tend to overestimate 
mortality because they usually concentrate on single causes without considering 
co-morbidity (2). 
6. Cause of death models: these are statistical models that allow prediction of 
the mortality attributable to one cause or cause category from all cause mortality. 
They are based on the postulation that cause specific mortality is a linear function 
of all cause mortality. Compositional models were developed using compositional 
data and are used to predict the distribution of all cause mortality over broad cause 
categories (12). They are also used to control deviations of the empirical mortality 
distributions from the predicted pattern (2). A spreadsheet program called 
CODMOD uses these models to analyze deviations of observed cause of death 
patterns or construct them (12). 
7. Hospital data: these can be used only where a high proportion of deaths 
occur in hospitals. 
8. Cancer registries: these record cancer deaths. 
In analysing the burden of disease, a comprehensive list of causes of death is 
prepared. When these are obtained from vital registration, it is recommended that 80% or 
more of all deaths are given specific ICD codes. Deaths in ill defined categories are 
reallocated to other specific categories using algorithms (2). 
The GBD study developed a list of causes that are of public health importance 
globally. It has four levels of disaggregation and the revised list includes 135 diseases and 
injuries. It is broadly divided into: 
Group 1 causes: communicable diseases, maternal causes, perinatal 
conditions, nutritional conditions 
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Group 2:  non communicable diseases 
Group 3:  intentional and unintentional injuries 
Deaths and nonfatal outcomes are attributed to single causes according to the rules of 
the International Classification of Disease (ICD) (4). 
For Sudan the cause of death data was developed by the GBD as follows: The pattern 
of deviation of the broad cause of death data of South Africa (good quality vital 
registration data) from the pattern predicted by cause of death models was applied to all 
cause mortality to calculate mortality rates in broad groups (groups 1, 2 and 3) (13). The 
preliminary estimates for more detailed causes were obtained by applying the pattern of 
cause specific mortality of Egypt (4).  
Validation of  cause of  death data  
The GBD developed preliminary estimates of mortality that were then validated and 
adjusted. Validity checks that can be used for this process are: 
1. Demographic plausibility of the data on causes of death.  
2. Specificity of some diseases to certain age and sex groups such as breast and 
prostate cancer. 
3. Some cancer deaths follow a standard well defined age pattern and data 
giving different patterns should be re-examined. 
4. If more than 10% of all deaths are coded to senility and ill defined causes, 
an investigation of a sample of these deaths should be done using verbal 
autopsies, death certificates, and medical records. 
5. Cause of death models can be used to compare their predicted broad 
pattern with the one derived from the data (2). 
Life expectancies 
Life expectancy at a certain age is the time expected to be lived in the future by a 
person at that age. YLLs use life expectancies at the age of death. This is the time that has 
been lost by a death at that age. Different sets of life expectancies give different types of 
YLLs. 
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Type of  YLLs 
Potential years of  life lost (PYLLs) 
This uses a potential limit of life chosen arbitrarily. Duration of life lost by the death 
of a person at a certain age is the potential age limit minus age at death. It is easy to 
calculate and treats all ages equally but deaths beyond the limit do not contribute to the 
burden of mortality. 
Period expected years of  life lost (PEYLLS) 
These are local life expectancies from a period life table for a population. Here deaths 
at all age contribute to the mortality burden. However using local numbers limits cross 
population comparability. They are not useful for measuring the burden for the same 
population at different times due to their variation over time and across populations. 
Moreover, poor communities with low life expectancies will paradoxically have lower 
burdens than rich communities with high life expectancies. 
 
Cohort expected years of  life lost (CEYLLs) 
Period life expectancies assume that age specific mortality rates remain unchanged, 
which is not always valid. Mortality has been declining over the last decade so that life 
expectancy of a cohort at each age has been increasing. It is more suitable to use life 
expectancies from a cohort life table (ideally based on following up a cohort till the death 
of its last member but can also be developed by projecting mortality rates). However 
cohort life expectancies also limit cross population and over time comparability. 
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Standard life expectancies (SLE) 
These are life expectancies from standard life tables. They were developed and used in 
the GBD. These are based on the highest life expectancy at birth which is that of 
Japanese females (82.5 yrs). The Coale and Demeny West model life table level 26 (14), 
with a female life expectancy at birth of 82.5 years, was used for female standard life 
expectancies. As for males, a difference in life expectancy was taken as 2.5 years lower 
than females. Since there is no model life table for male life expectancy at birth of 80 
years, the Coale and Demeny West model life table level 25 with a female life expectancy 
at birth of 80 years was used for male standard life expectancy (14). Differences between 
SLE of males and females were allowed to reveal to public policy the difference in 
survival potential between the sexes resulting from a number of genetic and 
environmental factors. This will permit public policy to deal with these factors to narrow 
the differences in survival potential. However this remains a controversial issue. Standard 
life expectancies are used for all populations at all times and therefore address the short-
comings of all the other sets of life expectancies (3). 
 
Morbidity component  
Years lost due to disability (YLDs): This is a function of the total time lived with 
disability and a weight given to that time.  
Total time lived by the population with disability: 
This can be expressed as the prevalence times one year or the incidence times the 
average duration of disability. The second approach is preferred in DALYs because: 
1. It is consistent with method of calculation of YLLs, mortality rates being 
incidence rates. 
2. Incidence rate is sensitive to current epidemiological trends. 
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3. Using incidence or deriving it from prevalence gives a chance for checking 
the internal consistency of the epidemiological estimates used in calculation 
of YLDs. 
4. The best measure for assessing intervention benefits is the volume of life 
years added.     
The two approaches yield the same results if the incidence of disability and the 
population age structure are constant over time (3).  
A reliable incidence rate and average duration should be consistent with other 
epidemiological estimates such as prevalence, mortality, case fatality rates and remission 
rates. The process that can be used to obtain internally consistent estimates is as follows: 
1. Researching current knowledge of the disease: supplemented with expert opinion, 
this is useful to understand the natural history of the disease. 
2. Constructing a diagram of the natural history of the disease: this shows the 
epidemiological dynamics of the disease and the transfer from susceptible state to 
disease state and complication and or death or recovery. It is also useful in 
clarifying the case definition, and identifying the epidemiological estimates needed.  
3. Searching for epidemiological estimates in:  
a. Disease registers: such as for infectious diseases, cancer, congenital 
anomalies, diabetes and epilepsy. They register new cases of disease. 
b. Population surveys: 
Provide prevalence of disease and disability some of which are self 
reported. They are limited by representativeness, case definitions, self 
reporting nature of the answers, and study quality. 
c. Epidemiological studies: can provide data when there are no disease 
registers or good quality surveys. Especially useful are longitudinal studies 
of the natural history of the disease, providing information about sequelae, 
case fatality, remission and average duration. 
d. Health facility data: due to problems of under-coverage, under-reporting 
and non-representativeness, health facility data can only be useful as source 
of morbidity data for serious conditions. These include: maternal and 
perinatal conditions, meningitis, stroke, myocardial infarction, surgical 
conditions and serious injuries. 
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Checking data quality 
The data available should be of the highest quality attainable. It should be plausible 
with the known epidemiology of the disease, adjusted for non representativeness and 
examined by experts. Computer software is used to check the internal consistency of the 
estimates. DISMOD is a type of software that processes a certain input set of 
epidemiological estimates to produce an internally consistent output set.  
The software is based on the following dynamic disease model: 
 
Population
without disease
Cases of disease Cause-specific
deaths
Deaths from
other causes
Remission
Rate r
All other
mortality rate
m
Case fatality
rate f
Incidence
Rate i
m
 
Source: National burden of disease studies: a practical guide (2) 
It accepts for input at least 3 of the following epidemiological estimates: 
1. Incidence rate 
2. Prevalence 
3. Remission rate 
4. Case fatality rate 
5. Mortality rate 
6. Average duration 
7. Relative risk of mortality. 
 Case fatality, remission and mortality rates should be instantaneous rates (hazards) 
with a person time denominator. In the most recent version of the software (15), 
Incidence rate can be entered as a hazard or as a population rate with a mid year 
population as denominator. Case fatality and relative risk of mortality are considered the 
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same and one suffices for the other. Only short average durations are accepted (less than 
2 years) but the remission and/or case fatality should be high. 
DISMOD is used for the following purposes: 
1. Checking internal consistency of epidemiological estimates. 
2. Calculating incidence from prevalence when the former is unavailable. 
3. Calculating average duration from incidence, remission and case fatality 
rates. 
4. Extrapolating estimates in desired age categories from estimates presented 
in different age categories. 
Disability weights  
These are numerical values given to time lived in non fatal health state. They quantify 
the society's preference for different health states and do not represent the experience of 
a person living in these states, nor do they quantify the value of a person living in a 
suboptimal health state. They range from 0 to 1. For DALYs, 0 is perfect health and 1 
represents death. 
The valuation is done in some form of interview of a number of respondents with 
space for deliberation using the following techniques: 
1. Rating scale/ visual analogue 
2. Standard gamble 
3. Time trade-off 
4. Person trade-off. 
The respondents can be of 5 types: Individuals experiencing the health states to be 
valued, health care providers, general public and patients’ families. 
The design of disability weights assumes that: 
1. A series of health states can be defined using an established instrument or 
other descriptors.  
2. Individuals’ preferences for time lived in different health states can be 
expressed in values.  
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3. These preferences can be measured using an interview or questionnaire. 
4. The severity of a health state and the time spent in that state are 
independent.  
A group of health states representing a full range of states from very mild to very 
severe are selected and described to the respondents. They can be described using 
standardized domains of health as those in existing classification systems such as the 
health utilities index. They may also be described ad hoc. Tools such as pictures, cartoons 
or multimedia presentations may be used to aid the description (2).  
The GBD developed and used a protocol for disability weight measurement. 22 
indicator conditions were selected to represent a wide variation of health states from very 
mild to very severe states, and to include many health domains: physical, mental and 
social. A variant of the person trade off method was used to develop disability weights 
for these conditions, by a group exercise involving a deliberative process. Other 
techniques were used to encourage respondents to examine their preferences carefully. 
There was a high agreement between the respondents with Spearman Correlation 
Coefficient more than 0.86. Eight other groups from over 25 countries did the same 
exercise and correlation coefficients among them were higher than 0.87. Based on this, 7 
classes of disability weights from 0 to 1 were developed. Each class contained 2 or 3 
indicator conditions. The rest of the diseases and injuries were then distributed among 
the 7 classes by the respondents using a rating scale. For some conditions, different 
disability weights were developed with and without treatment (16). Except for a few 
conditions co-disability was not considered. This means that disability weights for 
coexisting conditions are the simple sum of the disability weights for each condition. This 
sometimes leads to disability weights more than 1. Disability weights were developed for 
Down's syndrome with mental retardation and cerebral palsy and mental retardation. 
Dependant co-disability should be adjusted for while independent co-disability needs not, 
because correcting for the latter will lead to a bias with higher burden in low disability 
populations and vice versa.(3). 
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Dutch disability weights were also developed. They use different indicator conditions 
and they were developed for a restricted group of conditions. They were used in the 
Australian burden of disease study where adjustments for co-morbidity were made for 
the following conditions: 
1. Common coexisting nonfatal conditions of old age such as diabetes, hearing 
loss and osteoarthritis. 
2. Some mental health disorders. 
3. Congenital malformations 
4. Injuries (17). 
Disability weights were also developed and used in the work of the Ghana Health 
Assessment Team. They were developed through expert opinion and community 
participation. They are referred to as disability extent or percentage disablement 
(expressed as percentages) (18). 
Other social values 
Discounting 
This is applying a certain discount rate to years lost in the future. It is important in 
economic analysis and is used for DALYs for the following reasons: 
1. To be consistent with the measurement of health outcomes in cost 
effectiveness analyses. 
2. To prevent deaths at younger ages from having a higher weight. 
3. Without discounting, research or disease eradication programs with a non-
zero probability of succeeding will receive all current expenditure because 
its future benefits will be infinite. GBD applied a discount rate of 3%, 
which is less than the 3.5 recommended by economists (2). 
Age weighting 
The GBD applied lower weights to years lost at the young and older age groups than 
the other groups because some studies showed a wider social preference to time lived by 
a young adult than the same time lived by a young child or at older ages. It is argued that 
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this is inequitable and that the standard age weights used in the GBD do not reflect 
actual social values (2).  
Because discounting and age weighting are controversial issues, the GBD reports 
results with no discounting or age weighting (2). 
PRECISION OF THE DALY ESTIMATES 
Uncertainty analysis is the process by which confidence or uncertainty intervals are 
made around the DALY estimates. They describe explicitly the precision of the estimates 
derived from limited data sources. Analytical methods can be used to quantify uncertainty 
for simple quantities but complex quantities require simulation methods, such as the 
Monte Carlo simulations used in the GBD. Uncertainty may arise from: 
1. Incomplete information 
2. Bias in information such as non representativeness. 
3. Disagreements between information sources. 
4. Model uncertainty 
5. Uncertainty in preferences. 
6. Uncertainty inherent to the data generation process (e.g. using event counts 
to infer risk) (19). 
The difference between sensitivity and uncertainty analysis is that the former involves 
deterministic variation of the social values included in the estimation of DALYs while the 
latter involves varying the parameters used such as incidence rates. Uncertainty analysis 
can not be applied to the social values (3) 
NATIONAL BURDEN OF DISEASE STUDIES 
The first study to quantify the burden of disease in a Least Developed Country using 
the combined mortality and morbidity approach was conducted in Ghana. It used the 
Healthy Days of Life Lost. This indicator differs from DALYs in that it uses the life 
expectancy at the age of onset of disease instead of life expectancy at age of death, to 
calculate the mortality components. It expresses burden in days and uses local disability 
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weights. In Ghana, communicable diseases, perinatal and maternal conditions and 
nutritional deficiencies were predominant (18).   
Healthy days of life lost were later developed into healthy life years with the same 
method of calculation but burden expressed in years (20). The use of the life expectancy 
at age of onset of disease rather than the life expectancy at the age of death is argued to 
be a more appropriate approach to quantifying the consequences of disease onset and 
interventions. The time of onset perspective is considered by some to be useful because it 
is based on the natural history of disease concept. By emphasising the consequences of 
new disease cases, HeaLYs are more useful in thinking of disease prevention whereas 
DALYs being based on a current year perspective are claimed to be more useful for 
disease treatment interventions. The difference between DALYs and HeaLYs becomes 
more evident in diseases with secular trends such as HIV (21). HeaLYs were used to 
measure the burden of disease in Pakistan. The burden was predominantly of 
communicable diseases, perinatal conditions and nutritional deficiencies. However the 
study revealed the emergence of non communicable diseases and injuries, showing the 
state of epidemiological transition (22).  
Mexico quantified the burden of disease in 1991 using DALYs. The study used the 
same methods as the GBD 1990 but with some modifications. The study analysed the 
burden for 32 Mexican states separately. It revealed predominance of non communicable 
conditions at the national level as well as regional discrepancies, with a high burden in 
disadvantaged states predominantly of group 1 diseases. The study provided results 
useful for health system reform and mobilized a large no of experts in different diseases 
and conditions, to discuss health priorities. It also helped in identifying health 
information gaps (23). 
In Australia, the burden of disease was measured for 1996 using DALYs. The study 
differed from the GBD in that it used or derived disability weights from the GBD as well 
as disability weights developed in the Dutch burden of disease study. Adjustments were 
made for co-morbidity. The 15 leading causes of DALYs lost in 1996 in Australia were 
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non communicable diseases and injuries. The study initiated cost effectiveness analyses 
for cancer, coronary heart disease and mental disorders control (17). The state of Victoria 
in Australia also conducted a separate burden of disease study with similar methods and 
adjustments. (24).  
In South Africa the national burden of disease study used DALYs and disability 
weights from Australian NBD and GBD. The study also projected the burden of 
HIV/AIDS to the year 2010, and analysed the sensitivity of the YLLs to discounting and 
age weighting and to changing the standard life expectancies to local life expectancies. 
HIV/Aids caused the highest burden in terms of DALYs and it was the first cause of 
premature mortality. Other top causes of burden included injuries, perinatal conditions 
and non-communicable diseases (25). 
THE CONDITIONS UNDER STUDY: GLOBAL AND REGIONAL BURDEN 
 In 2002 malaria was the 9th leading cause of burden accounting for 3.12% of the total 
burden of disease . In the Eastern Mediterranean region it was the 16th leading cause of 
burden (1.6%). Measles accounted for 1.44% of global burden and 1.78% of regional 
disease burden, ranking 19th and 13th respectively. Protein energy malnutrition was the 
23rd cause of burden globally (1.13%) and the 19th regionally (1.47%). Low birth weight 
was the 9th leading cause of DALYs lost globally accounting for 3.11% of total disease 
burden and the 4th regionally (4.72%). Maternal hemorrhage ranked the lowest among 
this group (72nd globally and 58th regionally). Diabetes mellitus and road traffic accidents 
were the 26th and 11th leading causes of burden globally respectively. At the regional level 
they were the 33rd and 8th respectively (26).   
PRIOR ESTIMATES OF DISEASE BURDEN FOR SUDAN 
Although no local burden of disease study was conducted specifically in Sudan, the 
GBD developed prior estimates for all WHO member states including Sudan using 
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various methods. The following methods were used to calculate country specific 
estimates for the diseases under study: 
Malaria: country to sub-regional mortality ratio was applied to regional prevalence 
estimates (4). 
Measles: country specific data were used to develop country specific estimates of 
measles incidence using a model based on demographic data, vaccination coverage and 
vaccination efficacy. It also used case fatality ratio from several studies (27). 
Protein energy malnutrition (28): Country specific estimates were obtained from 
recent national surveys in the WHO member countries. 
Maternal hemorrhage: the GBD estimated regional incidence of postpartum 
hemorrhage using multi-center studies that were not based on self reporting. It was 
adjusted for the availability of treatment as indicated by the proportion of births attended 
or managed expectantly or actively by skilled birth attendants. Mortality rates were 
predicted from all cause maternal mortality. The regional incidence to mortality ratios for 
each age– sex group were applied to country specific mortality due to maternal 
hemorrhage to calculate the country specific incidence of maternal hemorrhage (29). The 
same method was used for low birth weight (4). 
Diabetes mellitus: for Sudan the national survey conducted in northern Sudan in 
1992 (30) was used as a source of the prevalence rate (31). 
Road traffic accidents: For all types of injury, age- and sex-specific ratios of incident 
non-fatal events to deaths were used to estimate regional incidence rates from health 
facility data. Incidence to mortality ratios were applied to country specific mortality to 
calculate country specific incidence (32).  
The estimates were developed for the year 2000 and then adjusted for 2002 using 
mortality projections and epidemiological trends (4). 
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The following table shows prior DALY estimates for Sudan for the selected diseases 
as reported in the GBD 
Table 2: Prior DALY estimates for Sudan for the selected diseases reported in the GBD 2002 revision 
Malaria Measles PEM Low birth weight 
Maternal 
haemorrhage 
Diabetes 
mellitus 
Road traffic 
accidents 
787099 
 
205608 
 
190602 
 
252847 
 
50342 
 
82849 
 
362500 
 
Source: Prior estimates of incidence, prevalence, mortality and average duration for Sudan in 2002 (33) 
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MATERIALS AND METHODS 
 
STUDY DESIGN 
Descriptive synthetic case study 
 
STUDY AREA 
Geographic profile 
 Sudan is an African country with a total area of 2,506,000 squared km (about 1 
million square miles). It is divided politically into states: 
Khartoum state, the capital, Nahr-Elnil state, Northern state, Red Sea, Kassala, 
Gadarif, Al-Gezira, Sinnar, Blue Nile and White Nile states, Northern, Southern and 
Western Kordofan states, Northern, Southern and Western Darfur states. The southern 
states include: Upper Nile state, Jonglei state, Unity state, Warab state, Lakes state, Bahr 
Aljabal, Northern Bahr Algazal, Western Bahr Algazal, Eastern Equatoria and Western 
Equatoria states (33). 
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Demographic and economic profile 
Table 3: Some demographic and economic indicators for Sudan in 2002: 
Total population 32,769,000 
Annual growth rate 2.63% 
Sex ratio 98.5 males per 100 females 
Crude birth rate 37.8 per 1000 population 
Crude death rate 11.5 per 1000 
Population under 5 yrs 15.89% 
Population 5 – 24 yrs 45% 
Women in reproductive age 15.13% 
Urbanization 34.8% 
Male life expectancy at birth 52.5years 
Female life expectancy at birth 55.5 years 
Per capita GNP $US 330 
Per capita GDP $US 570 
Adult literacy rate 49.9% 
Economically active population (10 
years and over) 
48.5% 
Source: Annual Statistical Report 2002 (34)  
Health profile 
According to the results of the multiple indicator cluster survey, the infant mortality rate 
in 2002 was 108 per 1000 live births for males and 99 per 1000 live births for females. 
40% of the population did not have access to improved source of drinking water (35). 
Maternal mortality was 509 per 100,000 live births (36). Sudan is categorized by the 
WHO (World Health Organization) in mortality stratum D, i.e. high child mortality and 
high adult mortality (7).  
HEALTH RELATED DATA SOURCES 
A/ Vital registration system 
The records of births and deaths in the population of each state are kept by the state 
bureau of statistics. It covers all the 16 states in the north but only 3(Upper Nile, Bahr – 
Elgazal and Equatoria) of the southern states. In the past years deaths were registered by 
all health facilities available in an area: hospitals, health centers, dispensaries, and by 
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community leaders and peoples committees. These might or might not issue a death 
certificate depending on the legal need for it. While all deaths occurring in hospitals were 
registered, not all deaths occurring in the community were so. In more recent years, only 
deaths with death certificates signed by a doctor were registered, which further reduced 
the death registration (personal communication, Khartoum state Statistical Bureau, 2002). 
In-patient hospital deaths are reported monthly to state ministries of health which report 
them to the Federal Ministry of Health. The causes of death are coded using the ICD – 
10 (International Classification of Disease), the data summarized by age, sex, state and 
cause and published in a yearly report together with other health facility statistics (34). 
Causes of death are not available for all registered deaths. The available data varies in 
quality. Only hospital in-patient deaths and those which were examined post – mortem 
are medically certified and therefore have information on causes of death. Cause of death 
data for some of the rest of the deaths is obtained by lay reporting. The GBD study 
estimated vital registration coverage for the region of Sub – Saharan Africa to be 1.1 % 
(13). Using the Brass – Growth – Balance method (2), adult (above 5 years) death 
registration completeness in 14 reporting states in Sudan in 2002 was 4.8%; 6.4% for 
males and 3.3% for females (Annex A).  
B/ Demographic censuses 
These are carried out every 10 years, the last census being in 1993. It covered all the 
northern states with the results for the southern states projected from the results of the 
1983 census. These censuses provide total population numbers by age and sex categories 
for each state, in addition to number of deaths during the census year by age, sex and 
state. Projections of the population size by age, sex and state are available at 5 yr intervals 
from 1993 to 2018 (37). 
C/ Routine health service records 
Data from health facilities are reported to the statistics department of the state ministries 
of health where they are compiled and monthly reports sent to the National Centre for 
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Health Information in the Federal Ministry of Health. It includes data about disease 
specific outpatient number of visits, inpatient admissions and deaths, in addition to the 
utilization of the different services in these health facilities (34).  
D/ National population surveys 
These are surveys that use a nationally representative sample of the population. Many 
surveys have been conducted in Sudan in the last decade. These include:  
1. Sudan demographic and health survey (SDHS): conducted in 1989/1990 and 
provides infant and maternal mortality and morbidity information as well as adult 
mortality (38). 
2. Sudan maternal and child health survey (PAPCHILD): conducted in 1992/1993 
for northern Sudan and 3 states in southern Sudan, and provided information 
about many aspects of maternal and child health including maternal, infant and 
child mortality rates, adult female mortality rate, and prevalence of childhood 
diseases and accidents (39).  
3. Safe Motherhood Survey (SMS): conducted in 1999, this was a comprehensive 
survey of reproductive health status in Sudan. It provides maternal, infant and 
child mortality rates and reproductive morbidity rates. It covered only northern 
Sudan and 3 urban centers in southern Sudan (36). 
4. Multiple Indicator Cluster Survey (MICS) in 2000. They provide information 
about child health, some aspects of reproductive health and other health 
indicators, for all of northern and part of southern Sudan (35).  
E/ Other useful data sources  
Other sources available include surveys and surveillance data of varying quality and 
representativeness from the different communicable disease control programmes, 
Directorate of Primary Health Care, studies conducted by academic institutes, 
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governmental and non governmental organizations. Police and military forces records 
also contain data about the different types of injuries. 
STUDY POPULATION 
The study measured the burden of the selected diseases and injuries in all the population, 
males and females of all ages in the year 2002, at the national level. 
STUDY VARIABLES 
1. Demographic variables: 
a. Total midyear population by age and sex for the study population in the 
year 2002. 
b. All cause mortality rates by age and sex for the study population in the year 
2002.  
2. Cause of death data: 
Age, sex and cause specific mortality rates in the study population for the year 
2002. 
3. Standard life expectancies for each age and sex category.  
4. A set of at least three morbidity estimates of disabling sequelae of diseases and 
injuries, for each age and sex category of the study population. The estimates 
included: 
a. Incidence rate. 
b. Prevalence proportion. 
c. Remission rate. 
d. Case fatality rate. 
e. Relative risk of mortality. 
f. Average duration of each disabling sequelae for each age and sex group. 
5. Disability weights for each disabling sequelae.  
METHODS OF DATA COLLECTION 
A systematic review of related studies was carried out using the following search strategy: 
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Search of  local databases at: 
1. National research centre: the electronic data base was searched using the diseases 
names as keywords. The studies were extracted from the center’s library by 
photocopying or direct review and summarization. 
2. Sudan library – University of Khartoum: 
The electronic database and printed catalogues were searched for all health related 
postgraduate theses catalogued in the library (up to 2001), and concerning the 
diseases under study. The keywords used in the electronic search were formed of 
the diseases names. The studies reviewed were registered in the library by date of 
review, author, name and address of reviewer for ethical purposes. Because theses 
submitted after 2001 were not catalogued and one catalogue was still in press, the 
following sources of postgraduate theses of the University of Khartoum were 
searched: 
a. Faculty of medicine university of Khartoum library printed catalogue of 
postgraduate theses from health related faculties. 
b. Hand search of the archives of the Faculty of postgraduate studies – 
University of Khartoum, for theses from the faculties of Medicine, Science, 
Pharmacy and Public and Environmental health, submitted after 2001. 
3. The books of abstracts of the Department of Paediatrics and Child Health and the 
Department of Obstetrics and Gynaecology of the University of Khartoum. 
Relevant theses were obtained from the department libraries. The books also 
helped in identifying theses missed in the Sudan Library search. 
4. National medical specialization board: 
A printed list of all submitted theses was examined and eligible theses reviewed 
and summarized. 
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Search of  international databases 
The electronic databases, Pubmed, Ovid and Embase were searched using keywords 
formed basically of the disease name, sequelae, area of study, and other relevant words. 
Annex (B) shows a list of the keywords used. 
Electronic databases were searched to find research papers not listed in local databases 
and identify research done in Africa or internationally were no local study in a certain 
research area was found. 
 Abstracts were reviewed and eligible studies identified and obtained from open access 
data bases (Biomed Central, Ingenta, Blackwell Synergy, Ovid, Science Direct and 
HINARI). 
Individual contact with researchers at health research institutes: 
The institutes where contacted and areas of research and key researchers in the diseases 
under study identified and contacted. They were informed about the study and published 
papers were obtained in hard or soft copy. Unpublished work was obtained in documents 
or interview with the researchers. The researchers were asked to identify other 
researchers working in the same field and these were also contacted and information 
obtained in the same way. Researchers were also approached for papers identified from 
international databases but could not be obtained in full text. 
Non governmental organizations 
These were contacted for surveys and data from surveillance conducted by them in their 
specific project areas. 
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Reference tracing 
Papers and theses identified from databases search were screened for relevant references 
and these were searched in open access web sites, libraries and by contacting the 
researchers who participated in the studies. 
Federal Ministry of  Health data 
Reports and studies from directorates and administrations of the Ministry of Health were 
obtained.  
Annex (C) shows a list of all places contacted for data. 
Data collection tools 
1. Data collection checklist:  
This was used by the data collectors to record information from the abstract and 
sometimes from the full report, to aid in selection of the eligible studies. 
2. Study summary sheet:  
This was used to extract relevant information from full text reports or papers. It 
summarized the identifying information of the study, eligibility of the study, its quality 
and the relevant results (Annex D). 
Conduct of  the search 
The search was conducted by the investigator and 2 data collectors. The data collectors 
were trained on electronic search, extraction of full text reports from open access web 
sources, review of abstracts and filling data collection checklists. When the search was 
conducted by the data collectors, information about eligibility of the study was recorded 
by them in the data collection checklist. The investigator used the latter to select eligible 
studies, review them and summarize them in the study summary sheet. When the search 
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was done by the investigator, the eligibility was determined directly from the study. The 
study selection, review and summarization were done by the investigator only. 
Study eligibility criteria 
1. Health related population based studies. However hospital based studies were 
included for complications of the diseases where no population based studies 
could be found, for injuries and severe conditions of which most of the surviving 
cases are expected to be found in hospital. 
2. Local published and unpublished studies. International studies and regional studies 
were included only where no local ones could be found or when they were 
considered to be more reliable. 
3. Giving at least one of the following epidemiological estimates: 
a. Incidence rate or proportion with the duration. 
b. Prevalence proportion. 
c. Disease specific mortality hazard or mortality rate with the duration of 
follow up. 
d. Case fatality rate or the case fatality ratio with duration of follow up. 
e. Remission rate or remission ratio with duration of follow up. 
f. Average duration of the disease. 
g. Age distribution of the disease. 
h. Sex distribution of the disease. 
i. Distribution of complications. 
j. Relative risk of mortality. 
There were no restrictions regarding time of the study, geographical region, age groups or 
sex groups. 
The studies selected for use were the most recent, most representative, with the best 
methodological quality, and with some exceptions, applying the same case definition used 
for developing the disability weights of the GBD. 
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SOURCES OF THE DATA OBTAINED: 
• Localized and multi-center hospital based studies 
• Localized population based studies 
• National surveys 
• African and international studies  
• Official reports of the Federal Ministry of Health, Traffic Police, and the SPLM 
(Sudan People Liberation Movement) health secretariat. 
• NGO surveillance reports 
• GBD data  
ETHICAL CONSIDERATIONS 
In the case of unpublished data, a written informed consent was obtained from the 
investigator or the person in charge of the data. The consent explained the purposes of 
the study and guaranteed protection of the data Annex (E).  
DEVELOPMENT OF DEMOGRAPHIC ESTIMATES 
Total population in 2002 by age and sex 
Projections of the population size for the year 2002 were available by state only, without 
age and sex disaggregation. The 1998 – 2003 medium projections by age and sex were 
obtained from the CBS for Sudan (37), and the projections for the year 2002 were 
interpolated as follows: 
The annual growth rate for each age and sex group was calculated as follows: 
r = ln Pt/Po / t 
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Where r = annual growth rate. 
Pt is the population at the next projection year (2003) 
Po is the population at the base year (1998). 
t is the time interval between the base year and the next projection year.  
 
The population size for each age and sex group for the required year was calculated using 
the following formula: 
Pt = Po X ert  
Where  
Pt = population size to be calculated. 
Po = population at the base year. 
e is the natural number. 
r = annual growth rate. 
t = the interval between the base year and the required year.  
Source: Central Bureau of Statistics (CBS) 
Population size and composition for southern Sudan in 2000 were obtained from results 
of MICS southern Sudan (40), and projected to the year 2002 assuming an annual growth 
rate of northern Sudan of 2.6%. The data was provided for 3 age groups: <5, 5-17 and 
>17. It was used in the calculation of the burden of measles. 
The calculations were made on Microsoft Excel 2002 (41).  
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All cause mortality rates 
Death registration completeness for ages 5 years and above was assessed using the Brass 
– Growth Balance method (Annex A). It was found to be lower than the standard set for 
conduction of burden of disease studies, rendering vital registration system unsuitable for 
providing mortality data. 
All-cause mortality rates were calculated from the mortality envelope for Sudan, used in 
the GBD 2002 (33). The number of death reported in each age and sex group was 
divided by the midyear population of that group to obtain mortality rates for 2002. 
Calculations were made using Microsoft Excel 2002 (41). 
The total population and mortality rates were used as the demographic input for 
DISMOD. 
 
METHODS OF DEVELOPMENT OF INTERNALLY CONSISTENT EPIDEMIOLOGICAL 
ESTIMATES 
For all diseases under study, models were developed to calculate epidemiological 
estimates from the best and sometimes the only data available. In some instances the 
models were based on the GBD models. The methods used the case definitions and 
sequelae of the GBD. With one exception, it was assumed that there were no trends in 
the epidemiology of the diseases under study, due to lack of time series data. The models, 
assumptions, and data were revised and in some instances, modified by an expert in each 
disease. The experts were consulted separately. Annex F shows a list of all experts 
consulted at this step. 
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METHODS USED FOR EACH DISEASE 
MALARIA 
Sequelae, case definitions and disability weights: 
Sequelae  Case definition  
. Malaria
 
Infectious disease caused by  protozoa of the genus 
Plasmodium 
Disability 
weights 
 Episodes Attacks of chills, fever, and sweating due to Plasmodium 
infection 
0.183 
 Anaemia Defined using WHO criteria for mild to very severe 
anaemia. 
0.012 
Neurological    
sequelae 
Includes hemiplegia, aphasia, ataxia and cortical blindness. 0.458 
 
WHO criteria for mild to severe anaemia: 
                    Mild Haemoglobin of 100-109 g/l in pregnant women, 110-119 
g/l in children and adult women and 120-129 g/l in adult 
men. 
                    Moderate Haemoglobin of 70-99 g/l in pregnant women, 80-109 g/l 
in children and adult women and 90-119 g/l in adult men. 
                   Severe Haemoglobin of 40-69 g/l in pregnant women, 50-79 g/l in 
children and adult women and 60-89 g/l in adult men. 
Source: GBD 2002 (4). 
Preliminary estimates developed: 
1. Incidence of malaria cases in 2002. 
2. Average duration of malaria episodes, neurological sequelae and anaemia. 
3. Case fatality hazard. 
4. Proportion of malaria cases developing complications: anaemia and neurological 
sequelae. 
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Assumptions 
1. Under reporting of fever presumed malaria is the same for all age groups and 
remains constant through time. 
2. Underreporting of fever presumed malaria is the same in southern Sudan as in 
northern Sudan.  
3. The epidemiological demarcation between low endemicity and high endemicity 
areas follows the geographic demarcation between the northern and southern 
states of Sudan. 
 
Calculations 
The incidence of malaria was calculated as follows: 
Incidence of fever presumed malaria: 
The cases reported to the formal health system as malaria where considered as fever 
presumed to be malaria since some could have been diagnosed only on clinical basis. 
Even health facility confirmation of malaria was of variable validity (42,43). The degree of 
underreporting of fever presumed malaria for children below 5 was calculated as follows:  
The total number of reported cases below 5 years in 2000 (44) was divided by 26 to find 
the average biweekly incidence of episodes. The assumption was that the number 
represented single episodes and not more than 1 visit for the same episode.  
The biweekly incidence of fever treated as malaria in children below 5 years from the 
MICS 2000 for northern Sudan (45) was taken as a gold standard. It was divided by the 
average biweekly incidence from the reported cases to find the underreporting factor. 
This factor was assumed to apply for all ages since there was no validation data for ages 5 
years or more. It was also assumed to apply to the year 2002. The total number of cases 
reported to the formal health system of the northern states in 2002 as malaria (34) was 
multiplied by the underreporting factor. For southern Sudan, Sudan People Liberation 
Movement (SPLM) health secretariat report (46) gave the number of reported cases in 
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2002 and assuming the same underreporting factor, the total number of cases of fever 
presumed malaria was calculated for southern Sudan.  
To calculate the incidence of true malaria, the calculated number of episodes was 
multiplied by 30% for northern Sudan. This was the median value summarizing the 
results of population based studies that gave the percentage of fever presumed malaria 
episodes diagnosed as malaria with a positive blood film (47-49). A higher percentage 
(50%) was used for cases of the southern Sudan, since in this high endemicity area; the 
positive predictive value of fever was expected to be high. The numbers of true malaria 
episodes for northern and southern states were added to produce the total national 
number of episodes expected to have occurred in 2002. The incidence rate of malaria was 
found by dividing the number by the total mid year population.  
 
Disaggregation by age and sex: 
The age and sex specific incidence rate was calculated using  age - sex ratios developed 
from a longitudinal study in a hypoendemic area (50) and population based surveillance 
results for fever (excluding other infections) in a hyperendemic area (51). The ratios were 
developed by dividing each age and sex specific rate by the overall incidence of each 
study, standardized for age using the Sudan population age structure. The age groups 
used for the input incidence where: <1, 1 -5, 6 – 10, 11 – 15, 16 – 20, 21 – 30, 31 – 40, 41 
– 50, >50. 
 
Average duration: 
The GBD 2000 assumption for Sudan, 0.011 years was used. Duration was an input 
because the remission was high and the duration was short. The duration was assumed to 
be the same for all age and sex groups (33) 
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Case fatality hazard: 
Only one study gave the case fatality ratio with the duration of hospitalization of the 
cases. The case fatality ratio from this study (52) was converted to a hazard using the 
following formula: 
Hazard = -ln (1 – p) / d (2) 
Where p is the proportion and d is the duration of follow up. 
Proportion of malaria cases developing anaemia: 
The proportion of malaria cases in all population groups, developing severe anaemia was 
reported in one study (52). The proportion of cases developing all forms of anaemia was 
calculated from this study by multiplying the proportion developing severe anaemia by 
2.5. This factor is the median of a range of factors derived from studies that report the 
proportions of all types of anaemia in different population groups (53-55). The 
proportion was assumed to be the same for all Sudan and for all the age – sex groups. 
Average duration of anaemia was assumed to be 1 year as in the GBD 2002 prior 
estimates for Sudan (33). 
Proportion of cases developing neurological sequelae: 
Due to lack of data, the proportion used was restricted to neurological sequelae from 
cerebral malaria. The same study used for the proportion developing severe anaemia was 
used for the proportion of cases developing cerebral malaria. Studies reported the 
proportion of cerebral malaria cases developing neurological sequelae for population 
group 0 – 9 only (56). A proportion reported in Nigeria was used (57). It was assumed to 
be the same for Sudan and for all age - sex groups. 
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DISMOD 
DISMOD was used to produce an output set for malaria episodes using the input set of 
incidence, average duration and case fatality hazard. The output incidence was used to 
calculate incidence of neurological sequelae by applying the proportion developing 
neurological sequelae from cerebral malaria. DISMOD was also used to calculate the 
average duration of neurological sequelae using the incidence rate, assuming a case fatality 
rate of 0 for all groups, and using a remission hazard, calculated from the remission 
proportion and duration of follow up of the Nigerian study (57) and assumed to be the 
same for all groups.  
 
Measles 
Sequelae, case definitions and disability weights: 
These are diarrhea, pneumonia and malnutrition. Burden of mortality from these 
sequelae was attributed to measles while burden of disability was attributed to the 
respective diseases. 
Case definitions and disability weights used: 
Disease Case definition Disability weight 
Measles episodes Acute and highly contagious infection with measles 
virus characterised by red, blotchy rash, fever, cough, 
coryza and conjunctivitis 
0.152 
Measles  death  Death occurring within 1 month after onset of measles  
Source: GBD 2002 (4). 
Preliminary estimates developed: 
1. Incidence rate. 
2. Case fatality hazard. 
3. Remission hazard. 
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Calculations 
The model used in GBD 2000 to calculate the global burden of measles was adopted 
(27). The model assumed the following: 
1. Universal infection: all susceptible children will ultimately contract measles (GBD 
assumption). 
2. No sex differences in disability or mortality (GBD 2000 assumption). 
3. Average duration of 2 weeks (GBD 2000 assumption). 
4. The burden of measles falls only on the age group 6 months – 19 years (GBD 
2000 assumption). 
Choice of the model was based on the fact that vaccination coverage in Sudan was less 
than 80% (40,45), no mass vaccination campaigns were conducted in 2002, and 
surveillance was not case based in 2002 (personal communication, Expanded program of 
immunization (EPI), 2004). 
 
Incidence: 
With the universal infection assumption, incidence of measles was calculated as follows: 
Total number of incident cases = susceptible birth cohort = Birth cohort in 2002 – (Birth 
cohort X VC X VE).  
Where VC is the vaccination coverage and VE is the vaccination efficiency. 
The birth cohort was calculated by multiplying the crude birth rate by the total 
population. Calculations were done separately for northern Sudan due to differences in 
the 2 factors. (34,40). Vaccination coverage for northern and southern Sudan was 
obtained from national surveys (40,45). Vaccination efficacy was 85% because the 
vaccine is given in one dose before the first year of age (27). Total incidence rate was 
calculated by dividing the total number of incident cases in northern and southern Sudan 
by the total population of Sudan. It was disaggregated into 4 age groups: <1, 1 – 4, 5 – 
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19, 20+ for both males and females. The age distribution of a small scale longitudinal 
population based study (58) was used as recommended by expert opinion. The incidence 
was assumed to be the same for both males and females.  
 
Case fatality hazard: 
 Only 2 studies gave the case fatality ratio and duration of follow up and their case 
definitions of measles mortality matched that of the GBD (59,60). Two different case 
fatality hazards were calculated, one from each study. 
 
 
Remission hazard: 
A remission ratio was calculated from each case fatality ratio by subtracting it from 1. 2 
remission hazards were therefore calculated. 
 
 
DISMOD 
Two input sets were used, with the same incidence rate and two different sets of case 
fatality and remission hazards. The input was processed and the output set that produced 
an average duration of 2 weeks (GBD assumption endorsed by expert opinion), was 
selected for use. The output incidence and mortality age distribution was different from 
that recommended by experts and only the overall incidence and mortality outputs were 
used. They were divided into the recommended age distribution.  
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Protein energy malnutrition 
Sequelae, case definitions and disability weights: 
 
Sequela 
Definition 
Disability 
weights 
Wasting Observed weight for height at least 2 standard deviations below 
the mean for 0-5 year old children. 
0.053 
Stunting Observed height for age at least 2 standard deviations below the 
mean for 0-5 year old children. 
0.002 
Developmental 
disability 
Limited physical and mental ability to perform most activities in all 
of the following areas: recreation, education, procreation or 
occupation 
0.024 
Source: GBD 2002 (4). 
Preliminary estimates developed: 
1. Prevalence of wasting 
2. Prevalence of stunting 
3. Prevalence of underweight 
4. Mortality hazard of wasting 
5. Incidence rate of wasting 
 
Assumptions 
1. Relative risk of wasting when comparing northern and southern Sudan applies also 
to stunting and underweight. 
2. Average duration of wasting is 5 years (GBD 2000 assumption) (28). 
3. The proportion of children developing developmental disabilities is the proportion 
that was underweight (GBD 2000 assumption) (28). 
4. Stunting and developmental disabilities are permanent (GBD 2000 assumption) 
(28). 
5. Mortality results only from wasting (GBD 2000 assumption) (28). 
6. No sex difference in wasting, stunting and underweight. 
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Calculations 
Prevalence of wasting: 
The prevalence data was obtained from national surveys and calculations were made 
separately for northern and southern Sudan.  
Northern Sudan: 
Trend in wasting was estimated using time series data from three national surveys 
(39,45,61). The prevalence reported in MICS 1995 (61) and 2000 (45) were adjusted for 
seasonal variation. The first was measured in the dry season and the second in the rainy 
season. Using a relative risk of 2 derived  from a longitudinal study (62), and assuming 
the same average duration in the dry as rainy season, the average prevalence proportions 
were calculated. More data points (one for each year) were created by linear interpolation 
between the original data points. The data fitted a cubic model and the prevalence in 
2002 was calculated using the following equation: 
Y = 3.11 + 12.11t – 2.56t2 + 0.15t3 
Y is the prevalence and t is time from t0 where t0 is 1993 
 
Southern Sudan: 
Trend was estimated from MICS 1995 (61) and MICS 2000 (40). The latter measured the 
prevalence of mid upper arm circumference less than 12.5cm. This was used to calculate 
the prevalence of wasting by adjusting it for less than perfect sensitivity and specificity, 
using the following formula: 
Apparent prevalence + specificity -1 
Adjusted prevalence= 
Sensitivity + specificity – 1 
Source: Epidemiologic methods for health policy (63). 
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The sensitivity and specificity from a study in Rwandan refugees was used (64). 
The prevalence of wasting in southern Sudan in 2002 was calculated by applying the 
estimated trend. 
The overall prevalence for Sudan was calculated for one age group 0 – 4 years by an 
average of the prevalence in northern Sudan and the prevalence in southern Sudan 
weighted by the mid year population under 5 of the 2 regions. 
 
Prevalence proportions of stunting and underweight: 
Northern Sudan: 
The trend was estimated from 2 surveys: the PAPCHILD (39) and MICS 2000 (45). It 
was applied to calculate the prevalence of stunting and wasting in 2002. 
Southern Sudan: 
This was estimated from the prevalence in northern Sudan by applying to it the wasting 
ratio of northern Sudan to southern Sudan. 
The prevalence proportions for northern and southern Sudan were pooled to calculate 
the overall prevalence of stunting and underweight. 
Mortality hazard of wasting: 
The mortality rate of wasting was calculated by applying a proportionate mortality of 
2.6% used in the GBD 2000 (28) to the under 5 mortality in northern and southern 
Sudan. A weighted average of the resulting specific mortality for the 2 regions was 
calculated and used as a mortality hazard, since at low rates, the population rate equals 
the hazard (2). 
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Incidence rate of wasting: 
This was calculated from the prevalence by applying an average duration of 5 years as 
assumed by the GBD 2000 (28). 
 
DISMOD: 
The software was used to produce an internally consistent incidence and mortality rates 
of wasting using the 3 preliminary estimates developed. It was also used to calculate the 
average duration of stunting and developmental disabilities using the prevalence and 
assuming case fatality and remission hazards of zero for each.  
 
Low birth weight 
Sequelae 
All developmental sequelae including cerebral palsy, mental retardation, epilepsy, hearing 
loss and visual loss have been grouped into one sequela (4). 
 
Case definition 
LBW: Birth weight below 2500g. It includes small-for-gestational-age infants and 
premature infants (4).  
Disability weights 
0.106 for all sequelae (4). 
Preliminary estimates developed 
1. Incidence hazard of low birth weight sequelae 
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2. Number of deaths in each sex group. 
Assumptions 
1. Rural and urban differences in the prevalence proportion of low birth 
weight in northern Sudan apply to southern Sudan. 
2. No sex difference in mortality rate of low birth weight. 
Calculations 
The calculations were done separately for northern and southern Sudan. For northern 
Sudan the prevalence of low birth weight was obtained from the SMS survey (36). For 
southern Sudan the prevalence was calculated for rural areas from urban prevalence (35), 
by applying the urban to rural prevalence ratio of urban to rural prevalence in northern 
Sudan assuming that the same differences exist in southern Sudan. The urban and rural 
prevalence proportions of southern Sudan were pooled to calculate the overall prevalence 
proportion. The prevalence proportions for northern and southern Sudan were then 
pooled to calculate the overall prevalence for Sudan. The disability hazard was calculated 
from data of a longitudinal study (65). It was applied to the prevalence of low birth 
weight to calculate the incidence hazard of low birth weight disability sequela. 
The number of deaths in each sex group was calculated by applying the proportionate 
mortality of 5.2% (GBD assumption) to the under five mortality for Sudan, calculated by 
pooling that for northern and southern Sudan (36). The mortality rate was assumed to be 
the same for males and females and the number of deaths in each group was calculated 
by applying the mortality rate to the mid – year population under 5 in each group in 2002.  
  
DISMOD: 
The software was used to calculate the average duration of disability from low birth 
weight for each age – sex category using the preliminary incidence hazard estimates and 
assuming a case fatality and remission hazards of zero. 
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Maternal haemorrhage 
Sequelae, case definitions and disability weights  
Sequelae  Case definition  Disability weights 
Severe anaemia from 
maternal hemorrhage 
Blood haemoglobin level < 10mg/dl 
following postpartum haemorrhage 
0.093 
Source: GBD 2002 (4). 
Preliminary estimates developed 
1. Incidence rate 
2. Remission hazard 
3. Mortality hazard 
Assumptions: 
1. The mortality burden is due to the immediate effect of haemorrhage.  
2. Severe anaemia is precipitated by haemorrhage in women with moderate anaemia 
at the time of delivery (GBD assumption) (29). 
Calculations 
Age specific incidence rate:  
2 sources were used: 
1. Safe motherhood survey (36) 
The incidence of PPH was calculated by multiplying the proportion of live births 
complicated by self reported PPH by the incidence of live births per 1000 women 
reported in the same survey. 
The incidence was calculated for the age group 15 – 49, divided into seven 5-year 
age groups, as in the data source used, to derive the incidence. The calculations 
were conducted separately for each age group. 
 
2. MOMA study (66): 
This was a multi-center population based longitudinal study in Africa. The 
incidence of PPH reported in the study was adjusted for the differences in 
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proportion of births attended by skilled birth attendants between the study 
population and Sudan population. Since no age specific incidence rates were 
reported in the study, adjustment for age could not be performed. The incidence 
of PPH in births attended by doctors, midwives and those not attended was 
calculated using the proportion attended by skilled birth attendants in the study 
group, and the following assumptions: 
a. The incidence of hemorrhage in births not attended by skilled birth 
attendants is twice that in births attended by skilled attendants with 
expectant management (29).  
b. The incidence in those managed expectantly is twice those managed actively 
(29). 
c. The proportion of births attended by midwives was managed expectantly 
and that attended by doctors was managed actively. 
The incidence rates were applied to the proportions in Sudan to calculate the 
overall incidence of postpartum hemorrhage. 
Mortality hazard: 
Three sets of mortality hazards were calculated from 3 different sources: 
1. The proportionate mortality from hemorrhage was derived from a number of 
hospital reports from different parts of the country (67-73). The median 
proportionate mortality was used to summarize the results of these studies and 
was similar to the value used in the GBD 1990 (74) and 2000 (29). The overall 
maternal mortality rate reported in the SMS (36) was assumed to be the same for 
all groups between 15 and 49 years. The maternal mortality per 100000 live births 
due to hemorrhage was calculated from the estimated proportion and the maternal 
mortality ratio. This was converted to maternal mortality per 1000 women for each 
age group using the incidence of live births per 1000 women in each age group. 
2. The case fatality ratio from a local hospital based study (75) was applied to the age 
specific incidence to calculate mortality. 
3. The case fatality ratio from the MOMA study (66) was applied to the age specific 
incidence. 
Remission hazard: 
This was calculated roughly from the case fatality ratio from the population based study 
assuming duration of 1 day. 
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Proportion developing severe anaemia: 
Two methods were used: 
1. The proportion was obtained from a local hospital based case study (75). The 
proportion was assumed to apply to all age groups between 15 and 49. 
2. An indirect method was also used. This method first calculated the proportion of 
hemorrhage cases that were anemic, assuming that this proportion will progress to 
severe anaemia after a hemorrhage episode. The method assumes independence 
between anemia and hemorrhage. The proportion of anemic cases was calculated 
as follows: 
The proportion of hemorrhage cases who attended antenatal care was calculated by 
a weighted average for the trimester specific proportions from the SMS (36). 
The proportion of live births with hemorrhage and attending antenatal care and not 
taking iron or folate supplementation was calculated using the proportion of 
antenatal care attendants (36) and the proportion of this not taking supplementation 
(36). 
Proportion not attending antenatal care and having hemorrhage was then added to 
the proportion of live births with antenatal care attendance, no supplementation and 
having hemorrhage. The joint proportion was multiplied by the probability of 
becoming anaemic in the absence of supplementation from a health facility based 
study of antenatal care attendants (76).  
Both methods gave very similar results.  
Average duration of severe anaemia: 
That of the GBD 2002 prior estimates for Sudan was used. 
 
DISMOD: 
The software was used to produce an internally consistent set by entering the input set 
and varying the mortality rate. The output incidence was used to calculate the incidence 
of severe anaemia by applying the proportion from method 1. 
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Diabetes mellitus: 
Sequelae, case definitions and disability weights  
Sequelae Case definitions 
Disability 
weights 
Cases 
Venous plasma concentration of µ 11.1 mmol/l 2 h after a 75g 
oral glucose challenge 
0.014 
Diabetic foot Chronic or recurring diabetic foot ulcers 0.134 
Neuropathy 
Loss of reflexes and of vibration; damage and dysfunction of 
sensory, motor or autonomic nerves attributable to diabetes 0.073 
Retinopathy – blindness 
Retinopathy: Microaneurysms or worse lesions in at least one 
eye; progressive damage of the small blood vessels of the retina 
Blindness: Unable to distinguish the fingers of a hand at the 
distance of 3 meters, or, has less than 5% of remaining vision 
as compared to a normally sighted individual; visual acuity of 
less than 3/60, or corresponding visual field loss in the better 
eye with best possible correction 
0.555 
Amputation 
Surgical elimination of the lower extremity or part of it because 
of gangrene 0.120 
Source: GBD 2002 (4) 
Preliminary estimates developed 
1. Prevalence of diabetes mellitus. 
2. Remission rate. 
3. Relative risk of mortality. 
4. Proportions of disabling sequelae. 
Assumptions 
1. Burden of diabetes mellitus is attributable to Type I and type II only (GBD 2000) 
(31). 
2. There are no differences in the burden of the 2 types (GBD 2000) (31). 
3. Equal sex distribution of disability. 
4. Equal age distribution of disability  
5. Amputations, neuropathy and diabetic septic foot will be assumed occur only after 
the age of 19 years (GBD 2000) (31). 
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6. Blindness due to retinopathy will be assumed to occur only after the age of 14 
years (GBD 2000) (31). 
 
Calculations 
Age and sex specific prevalence of disability: 
The prevalence was calculated differently for age groups: 0 – 14, 15 – 24 and 24+.  
Age group 24+ 
The age and sex specific prevalence was obtained from a population based study 
representing northern Sudan (30) and reporting in 3 age groups: 25 – 44, 45 -64 and 65+. 
For southern Sudan, the prevalence was assumed to be 1% derived from the relatively 
low prevalence proportions of neighboring African countries to the south of the Sudan 
(77) and recommended by expert. It was assumed to be the same for all ages above 24 
and for both sexes. The age and sex specific prevalence for all Sudan was calculated by 
first combining the overall prevalence for northern and southern Sudan through an 
average weighted by the population sizes. Then the new overall value was divided into 3 
age groups using the age and sex distribution of the prevalence in northern Sudan 
assuming that it also applies for southern Sudan. 
 
0 to 14 years: 
An incidence rate was available for this group (78) and was assumed to be the same for 
all Sudan. Prevalence was calculated from incidence by multiplying the latter by the 
average duration derived from the GBD 2002 prior estimates of average duration for this 
age group for Sudan (33). It was assumed to be the same for males and females. 
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15-24 years: 
There was no local data for this age group. A value was calculated by estimation from the 
age group 24+ using the distribution reported in the Saudi Arabia study (79) which 
considered the age group 15-29 years in addition to older groups. However the value 
estimated for males was much lower than that of females and lower than the other age 
groups. Because the distribution of the prevalence for males was inconsistent with local 
and regional GBD estimates (33), 2 more values were estimated for males as follows: 
1. By linear interpolation between the below 15 years and the above 24 years age 
groups. 
2. Assuming that the prevalence was the same as for females. 
 
Remission rate: 
This was 0 for all age and sex groups 
 
Age and sex specific relative risk of mortality: 
Relative risk of mortality for diabetes cases, used in the GBD 2000 (31) was adopted. For 
blindness due to retinopathy, a relative risk of mortality of 2.5 was used for both males 
and females (80,81). 
 
Proportions of disabling sequelae: 
Proportions from a multi-center study were used (82). No study reported the proportion 
developing diabetic septic foot or diabetic amputation or blindness. The proportion 
developing diabetic septic foot was estimated from the proportion developing angiopathy 
and peripheral neuropathy. The 2 latter conditions were assumed to be independent and 
their proportions were multiplied by each other to produce the proportion developing 
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both complications. 50% were assumed to develop diabetic septic foot if having both 
conditions (personal communication; Gabir Abuliz Diabetes Center, 2004) and the joint 
probability was therefore halved to produce the proportion developing diabetic septic 
foot. Other small scale health facility based case studies reported the percentage of 
diabetic septic foot patients undergoing amputations (83-85). The results of these studies 
were summarized by a weighted average to provide a proportion for diabetic amputation 
assumed to be resulting from diabetic septic foot only. The proportion developing 
advanced retinopathy was used as a proxy to the proportion developing blindness. As for 
blindness, the proportion developing advanced retinopathy was taken as a proxy to the 
proportion developing blindness. 
 
DISMOD: 
The input set was entered in DISMOD, and the prevalence in males in the age group 15-
24 was varied between the 3 values calculated to produce an output with an age 
distribution consistent with the GBD estimates. The software was also used to produce 
the incidence and average duration of diabetes mellitus cases and to calculate the average 
duration and incidence of diabetic neuropathy and diabetic amputation using the 
prevalence and assuming a case fatality and remission rates of 0. Diabetic septic foot 
duration was assumed to be 6 months as in the GBD. This was used together with the 
prevalence and a series of remission rates to produce an internally consistent output with 
the same average duration. The output for the average duration of diabetic septic foot for 
some age - sex groups was more than 6 months and these were changed to 6 months. 
The software was also used to calcualate the incidence and average duration of blindness 
using the prevalence, remission rate of 0 and the relative risk of mortality of blindness. 
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Road traffic accidents 
Case definition 
Road traffic accidents episodes include crashes and pedestrian injuries due to motor 
vehicles. An incident episode of non fatal injury is defined as “an episode that is severe 
enough for the person to be hospitalized or which requires emergency room care” (32). 
Sequelae 
One local hospital based study (86) reported on the injuries resulting from road traffic 
accidents and these were selected to be the sequelae to which the burden was attributed.  
 
Preliminary estimates developed: 
1. Incidence rate. 
2. Mortality hazard 
3. Case fatality hazard. 
4. Incidence of disabling sequelae. 
5. Relative risk of mortality. 
 
Assumptions 
1. Complete reporting of injuries from road traffic accidents. 
2. Different natures of injury at each site will be assumed to occur equally since the 
available distributions are by site of injury rather than nature of injury.  
3. Equal sex distribution across all subcategories. 
4. Equal treatment proportions for short and long duration injuries. 
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Calculations 
Incidence rate: 
The incidence was calculated from the number of incident road traffic accident injuries 
reported by age in the traffic police annual report in 2002 (87). The number of cases in 
each age group was divided into male and female cases using a sex ratio of 7:3 (86). The 
age – sex specific incidence was calculated by dividing the number of cases in each group 
by the mid year population in 2002 for that group. The incidence was assumed to hold 
for all Sudan. 
 
Case fatality hazard: 
The case fatality rate for each age group was found by dividing the no. of deaths reported 
(87), by the total number of incident cases. A number of case fatality hazards were 
calculated assuming different durations of follow up (1yr, 0.5 year, 0.25 year).  It was 
assumed to be the same for both males and females. 
 
Mortality hazard: 
The age and sex specific mortality rate was first calculated by dividing the no of deaths 
reported (87) by the total mid year population in 2002 for that group. The resulting 
population rate was used as hazard. 
 
Incidence of disabling sequelae: 
The proportion in each age group developing serious injuries was estimated from the 
annual report (87). Reported serious injuries are ones that required hospital transfer. 
These age specific proportions were applied to the output age specific incidence of road 
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traffic accidents to calculate the overall incidence of non fatal injuries for each age – sex 
group. The proportions were assumed to be the same for both males and females.  
The incidence of each disabling injury was calculated separately for each age and sex 
group by whether the cases were treated or not, and by whether the disability was long 
term or short term, because of the variation in disability weights by treatment 
proportions and variation in the average duration by both factors. The distribution of 
sequelae was obtained from a local hospital based study (86). Division into treated and 
untreated cases and long term and short term disability was made using GBD 2000 
proportions (32). 
 
Average duration: 
The average duration of disabling sequelae were obtained from the GBD 2000 (31), 
except for long term disability resulting from spine, skull and femur fractures, and from 
intracranial injuries.  
 
DISMOD 
The software was used to check the internal consistency of the preliminary estimates: 
incidence, case fatality hazard and mortality rates of road traffic accidents. The output 
incidence was used to calculate the incidence of disabling sequelae by applying the 
proportion developing serious injuries (calculated from report) to the output incidence. 
The software was also used to calculate the average duration of long term disability from 
spine, skull and femur fractures, and from intracranial injuries, using the incidence of 
these disabilities, remission rate of 0 and relative risk of mortality assumptions of the 
GBD 2000 (32).  
Calculation of all preliminary estimates was done using Microsoft Excel 2002 (41). 
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STANDARD LIFE EXPECTANCIES 
 The standard life expectancies from a model life table, the Coale and Demeny West level 
26 for females and level 25 for males were used (14). The standard life expectancies for 
the average age at death were interpolated from the life table, taking the average age at 
death of each age group as the midpoint for that group, except for the age groups <1yr 
and 1 – 4 years. For these the average age at death was taken as 0.3 years and 2.6 years 
respectively (2).  
DISABILITY WEIGHTS 
2 sets of disability weights, GBD 2000 weights and Ghana Health assessment team 
weights (22) were applied. The Ghana health assessment team weights were expected to 
be the most approximate to local preferences in Sudan. 
DATA ANALYSIS METHODS 
Calculation of  years lost due to premature mortality (YLLs) 
The mortality output of DISMOD for each disease and the standard life expectancy at 
the average age at death were used to calculate YLLs.  
The basic formula is: 
 YLL = N * L 
 Where  
N = the number of deaths in each age - sex group in 2002. 
L = the standard life expectancy for the average age at death.  
Total and age – sex specific YLLs were calculated. 
Source: National Burden of Disease Studies: A Practical Guide (2) 
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Calculation of  years lost due to disability (YLDs) 
For each disease, the incidence of each disabling sequela, originating from DISMOD, 
was used with the average duration and its disability weight to calculate YLDs. The YLDs 
for all the sequela were added together to find the total YLDs for that disease. This 
operation was done for each age – sex group. 
Formula used: 
 YLD for a disabling sequelae = N * L * DW (3). 
Where: 
N = the number of incident cases of disabling sequelae of the disease or injury.  
L = the average duration of disability.  
DW = the disability weight for the sequelae. 
Source: National Burden of Disease Studies: A Practical Guide (2) 
 
Calculation of  disability adjusted life years (DALYs) 
For each disease, YLLs and YLDs for each age - sex group were added to calculate age- 
sex specific DALYs. These were added to calculate the total DALYs lost for that disease. 
DALYs per 1000 population were also calculated. 
Sensitivity analysis 
YLDs were calculated again using the Ghana Health Assessment Team disability weights. 
Since there were no disability weights in this set that were specific for severe anaemia 
following postpartum hemorrhage, low birth weight and road traffic accidents, the 
disability weights for adult female anaemia, birth diseases and injuries were used for these 
conditions respectively. For malaria and diabetes, the average duration of the episodes 
and cases respectively were used, excluding the sequelae. For measles, low birth weight 
and maternal hemorrhage, there was only one sequela per disease and its average duration 
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was used. For road traffic accidents, the disability weights were applied to each of the 
sequelae with its average duration because the sequelae were considered independent. For 
protein energy malnutrition, the sequelae were dependant and the disability weight given 
to malnutrition in general was high. Since only wasting was considered to be a cause of 
mortality and since it had the highest GBD disability weight it was selected for the 
application of Ghana disability weight. The resulting DALYs were compared with 
DALYs calculated separately for wasting. 
The change in the burden of each disease for each age and sex group when using the 
Ghana disability weight set was calculated as a percentage of the burden when using the 
GBD weights.  
DATA ANALYSIS TOOLS 
Microsoft Excel 2002 spreadsheets (41) were used to calculate standard life expectancies, 
YLLs, YLDs and DALYS. 
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RESULTS 
NATIONAL INCIDENCE AND MORTALITY ESTIMATES 
The incidence and mortality rates of malaria by age and sex are shown in table 4. The 
incidence of malaria in males was 340.85 per 1000 and in females was 335.17 per 1000. 
The highest incidence for both males and females was in the age group 5 – 14 yrs. 
Mortality rate of malaria was 0.92 per 1000 and 0.90 per 1000 in males and females 
respectively. The age group 5 – 14 yrs in both males and females had the highest 
mortality as well.  
Table 5 shows the incidence and mortality rates of measles. The overall incidence in 
measles was lower in males (11.4 per 1000) than in females (12.45 per 1000). The 
incidence was highest in the age group 0 – 4 yrs for both males and females and declined 
to reach zero after the age of 29 yrs. The overall mortality was also lower in males (0.48 
per 1000) than in females (0.53 per 1000). As the case with the incidence, the mortality 
rate was highest in children less than five years for both males and females and declined 
to a very low rate in the age group 15 – 29 yrs after which it was zero. 
As shown in table 6, the overall incidence in males of wasting, stunting and 
developmental disability was, 4.03, 23.88 and 21.57 per 1000 respectively. The incidence 
of wasting was higher in females (4.25 per 1000) but the incidence of stunting and 
developmental disability was lower in females (23.26 and 21.01 per 1000 respectively).   
Table 7 shows the mortality rate of wasting in children less than five years which was 
almost equal for males and females (0.45 and 0.44 per 1000 respectively) 
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The incidence of disabling sequelae resulting from low birth weight in the first year of 
life (table 8) was the same in males as in females (0.1 per 1000) while mortality from low 
birth weight was higher in males than in females (1.16 versus 1.10 per 1000).  
Table 9 shows the incidence of severe anaemia resulting from maternal hemorrhage. 
It was the lowest in the age group 5 – 14 years and the highest in the age groups 15 – 29 
and 30 – 44 years after which it declined to relatively very low values. The overall 
incidence was 0.6 per 1000. The same table shows mortality from maternal haemorrhage. 
Unlike the incidence it is highest in the very old age group and the overall mortality was 
0.02 per 1000. 
In table 10 the overall incidence of diabetes mellitus was 0.77 per 1000 for males. It 
was higher for females (0.93 per 1000). The incidence was lowest in the age group 5 – 14 
years in both males and females. It increased to peak at the age group 45 – 59 in males 
and in the group 70 - 79 years in females. It then declined in the older age groups. 
Mortality was similarly higher for females than males (0.42 versus 0.33 per 1000 
respectively). It also followed the same age pattern as the incidence in males and females. 
The incidence of road traffic accidents (table 11) was much higher in males (0.21 per 
1000) than in females (0.09 per 1000). In both males and females it was highest in the age 
group 45 – 59 years (0.25 and 0.1 per 1000 respectively). Mortality was similarly higher in 
males than females (0.05 versus 0.02 per 1000 respectively) and peaked in the same age 
group as the incidence. 
DISABILITY ADJUSTED LIFE YEARS 
Figure II shows the DALYs lost per 1000 population due to malaria in males 
compared to females in each age group. The burden rose to peak in the age group 5 – 14 
years and then declined to a minimum in the age group 80+. Males were affected more 
than females up to 14 years but then females predominated all the way to the oldest age 
group. However, in the group 45 – 59 years, the burden was equal for both males and 
females.  
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The age and sex distribution of the burden of measles is shown in figure III. In both 
males and females the burden was highest in children less than five years and declined 
steeply to a minimum in the age group 15 – 29 years. Afterwards it was zero. The burden 
was highest in female children less than five years but was almost the same for both 
males and females in the other age groups.  
The burden of protein energy malnutrition was carried solely by children less than five 
years for both males and females (figure IV). In this age group, it was higher in females 
than in males. 
Figure V displays the burden of low birth weight by age and sex. The burden affected 
only infants and was higher in females than males. 
Figure VI shows 2 peaks in the age distribution of the burden of maternal 
hemorrhage. The first peak occurred in the age group 30 – 44 while the second peak 
occurred in the age group 60 – 69. The burden continued to be high in the next age 
group, to decline after the age of 79. 
As depicted in figure VII the burden of diabetes varied greatly between males and 
females. It was the lowest in the two youngest age groups in both males and females. In 
males it rose to a peak in the group 45 – 59 years while in females it peaked in the group 
70 – 79 yrs. The burden was higher in females up to the group 30 – 44 yrs but became 
lower in the group 45 – 59. In the higher age groups the burden was higher in females. 
The burden of road traffic accidents was higher in males than in females for all age 
groups (figure VIII). For both males and females the burden increased after the youngest 
age group to peak at the age 15 – 29 years and declined to a minimum in the oldest age 
group. 
Figure IX shows the rank ordering of the diseases by total DALYs for males. Low 
birth weight accounted for the highest burden followed by protein energy malnutrition. 
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Malaria ranked third while measles followed. Non communicable conditions (diabetes 
and road traffic accidents) had the lowest burdens.  
The figure also shows the relative contribution of disability to the total disease 
burden. The highest contribution was observed in protein energy malnutrition where 
disability accounted for almost half the burden while the burden of disability in low birth 
weight, measles and road traffic accidents was almost negligible when compared to the 
burden of mortality. 
Similar findings were observed in females (figure X). The same rank ordering of the 
diseases as in males was found. However maternal hemorrhage accounted for a higher 
burden than road traffic accidents. Low birth weight, measles, maternal hemorrhage and 
road traffic accidents also had a very low burden of disability compared to mortality. 
Table 12 displays the total DALYs lost by males due to the diseases under study by 
age and sex. In the age group 0 – 4 years in males, the distribution of burden among the 
diseases under study was similar as the overall distribution except that measles preceded 
malaria and road traffic accidents preceded diabetes mellitus. After the age of 5 years, 
malaria ranked first and was followed by measles then the non communicable conditions. 
After 45 years, diabetes preceded malaria but the order reversed at the oldest age group. 
In females (table 13), the distribution of burden among the diseases in children less 
than five years was the same as the overall distribution except that measles preceded 
malaria. The situation reversed in the age group 5 – 14 years and measles and malaria 
topped the list. This continued into the older age groups with the gradual emergence of 
maternal hemorrhage. In spite of that, diabetes mellitus always preceded maternal 
hemorrhage as the cause of DALYs lost. It accounted for the highest burden after the 
age of 45 years. 
Table 14 shows a slight change in the rank order of the diseases under study when 
using DALYs versus YLLs only. Protein energy malnutrition moved from third position 
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with YLLs to second position with DALYs, displacing malaria. The rest of the diseases 
preserved their rank orders. 
The differences between the DALY estimates of the study and the GBD prior 
estimates are evident in table 15. The rank order of the diseases in the study and the rank 
ordering of the GBD 2002 differed for all diseases except for measles and maternal 
hemorrhage which ranked fourth and seventh respectively in both lists. 
SENSITIVITY TO DISABILITY WEIGHTS 
Table 16 shows the percentage change in burden of malaria when using Ghana 
disability weights. Throughout all age groups the effect did not vary much between males 
and females. For both males and females the least effect was in the youngest age group. It 
rose with age to reach a maximum, with the burden almost doubling in the oldest age 
group. The overall effect of Ghana disability weights on malaria burden was a rise of 
about 11% for males and 10% for females. 
An overall increase in the burden of measles of 0.73% was observed for both males 
and females when using Ghana disability weights (table 17). The effect was highest in the 
age group 5 – 14 years for both sexes.  
Table 18 shows the effect on the burden of protein energy malnutrition. An increase 
in burden of 38.42% for males and 40.59% for females was observed. 
In the burden of low birth weight, the effect was very slight with an increase of about 
0.01% only (table 19). 
In maternal hemorrhage, only a small increase in burden was observed (table 20) 
Table 21 shows the effect on the burden of diabetes mellitus. In spite that the effect 
on the overall burden did not vary greatly between males and females (increase of 8.91% 
and 8.47% respectively); it varied widely between the age – sex groups. The largest effect 
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was a decrease in the burden of 71.63% in males and 44.39% in females in the age group 
80+ yrs.  
A generalized decline in the burden of road traffic accidents was observed (table 22). 
The decline in overall burden was more in females than in males (5.48% versus 2.67%). 
There was no wide variation in the burden between the age– sex groups. 
 Results 
 70
 
Table 4: Age and sex specific incidence and mortality rates of malaria per 1000 
population in Sudan in 2002  
 
 Incidence Mortality 
Age group Males Females Males Females
Less than 4 317.81 295.05 0.85 0.79
5-14 411.97 392.04 1.11 1.06
15-29 330.53 338.39 0.89 0.91
30-44 253.70 271.84 0.68 0.73
45-59 347.56 318.67 0.94 0.86
60-69 350.88 398.33 0.94 1.07
70-79 350.88 398.33 0.94 1.07
80+ 351.15 398.34 0.95 1.07
Overall 340.85 335.17 0.92 0.90
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Table 5: Age and sex specific incidence and mortality rates of measles per 1000 
population in Sudan in 2002  
 
 Incidence Mortality 
Age 
group Males Females Males Females 
Less 
than 4     28.31 31.65 1.34 1.50
5-14 19.95 22.36 0.79 0.88
15-29 5.05 5.62 0.18 0.21
30-44 - - - -
45-59 - - - -
60-69 - - - -
70-79 - - - -
80+ - - - -
Overall 11.40 12.45 0.49 0.53
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Table 6: Age and sex specific Incidence rates of wasting, stunting and developmental 
disability per 1000 population in Sudan in 2002  
 
 Wasting Stunting 
Developmental 
disability 
Age 
group 
Males Females Males Females Males Females
Less 
than 4 
25.03 27.12 148.18 148.42 133.85 134.07 
5+ - - - - - - 
Overall 4.03 4.25 23.88 23.26 21.57 21.01 
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Table 7: Mortality from wasting per 1000 population in Sudan in 2002 by age and sex 
 
Age group Males Females 
Less than 
4 2.82 2.80
5+ - -
Overall  0.45 0.44
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Table 8: Age and sex specific incidence of low birth weight sequelae and mortality of low 
birth weight per 1000 population in Sudan in 2002 
 
 Incidence Mortality 
Age 
group 
Males Females Males Females 
0 0.59 0.62 7.54 7.03 
1+ - - - - 
Overall 0.1 0.1 1.16 1.10 
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Table 9: Age specific incidence of severe anaemia resulting from maternal hemorrhage, 
and mortality from maternal hemorrhage per 1000 population in Sudan in 2002 
 
Age group Incidence Mortality 
Less than 4 - - 
5-14 0.05 0.002 
15-29 1.14 0.04 
30-44 1.47 0.05 
45-59 0.18 0.02 
60-69 0.04 0.11 
70-79 0.05 0.14 
80+ 0.05 0.15 
Overall 0.60 0.02 
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Table 10: age and sex specific incidence and mortality rates of Diabetes Mellitus per 1000 
population in Sudan in 2002 by 
 
 Incidence Mortality 
Age 
group Males Females Males Females 
Less 
than 4    0.01 0.03 0.01 0.03
5-14 0.01 0.01 0.01 0.01
15-29 0.21 0.88 0.04 0.12
30-44 0.57 1.02 0.22 0.56
45-59 6.74 2.76 2.33 1.21
60-69 1.31 6.24 2.29 3.28
70-79 2.53 12.29 3.08 11.76
80+ 0.28 0.84 0.31 0.86
Overall 0.78 0.93 0.33 0.42
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Table 11: Age and sex specific incidence and mortality rates of Road traffic accidents per 
1000 population in Sudan in 2002  
 
 Incidence Mortality 
Age 
group 
Males Females Males Females 
Less 
than 4    0.06 0.03 0.01 0.01
5-14 0.10 0.05 0.03 0.01
15-29 0.22 0.10 0.07 0.03
30-44 0.34 0.14 0.06 0.03
45-59 0.47 0.19 0.08 0.03
60-69 0.38 0.17 0.06 0.03
70-79 0.33 0.14 0.04 0.02
80+ 0.32 0.14 0.04 0.02
Overall 0.21 0.09 0.05 0.02
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Table 12: Total DALYs lost by males in Sudan in 2002 due to the diseases under study, 
by age and sex  
Age group Less than 4 5-14 15-29 30-44 45-59 60-69 70-79 80+ Total 
Diabetes 2126.88 4157.73 1743.80 27617.39 97790.13 19245.52 5107.49 674.02 174153.80 
Road traffic 
accidents 3043.45 9572.90 20564.73 7758.91 3559.05 515.06 74.90 19.54 45108.53 
Low birth 
weight 1438658.18 - - - - - - - - 
Maternal 
hemorrhage - - - - - - - - - 
Measles 442673.83 88726.56 39665.10 - - - - - 571065.49 
Malaria 192238.50 373415.81 283597.99 85896.58 44781.23 9049.11 1916.99 688.72 991584.93 
Protein 
energy 
malnutrition 
1093365.87 - - - - - - - 1093365.87 
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Table 13: Total DALYs lost by females in Sudan in 2002 due to the diseases under study, 
by age and sex  
Age group Less than 4 5-14 15-29 30-44 45-59 60-69 70-79 80+ Total 
Diabetes 5769.56 7107.84 43890.12 81962.44 58595.87 28978.11 21022.54 1109.2 248435.67 
Road traffic 
accidents 1281.15 4150.54 8826.70 3513.13 1536.86 220.83 24.83 4.15 19558.19 
Low birth 
weight 1590709.35 - - - - - - - - 
Maternal 
hemorrhage - 672.79 10434.38 7205.44 751.50 912.68 250.12 71.69 20298.60 
Measles 447774.55 89748.55 40121.91 - - - - - 577645.00 
Malaria 176575.18 356327.12 286812.63 105868.07 46084.61 11161.92 2341.21 871.72 986042.47 
Protein 
energy 
malnutrition 
1095783.65 - - - - - - - 1095783.65 
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Table 14: Rank order of the diseases under study using YLLs versus DALYs 
Using YLLs Using DALYs 
Low birth weight  Low birth weight 
Malaria  Protein energy malnutrition 
Protein energy malnutrition Malaria  
Measles  Measles   
Diabetes Mellitus Diabetes Mellitus 
Road traffic accidents Road traffic accidents 
Maternal hemorrhage Maternal hemorrhage 
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Table 15: Rank order of the GBD 2002 compared to that of the study using total DALYs: 
 
Study GBD 2002 
1. Low birth weight 1. Malaria 
2. Protein energy malnutrition 2. Road traffic accidents 
3. Malaria 3. Low birth weight 
4. Measles 4. Measles 
5. Diabetes Mellitus  5. Protein energy malnutrition
6. Road traffic accidents 6. Diabetes Mellitus  
7. Maternal hemorrhage  7. Maternal hemorrhage  
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Table 16: Percentage change in burden of malaria in Sudan in 2002 when using Ghana 
disability weights, by age and sex: 
 
Age group Males Females 
Less than 4   7.71 7.16
5-14 9.62 9.10
15-29 10.55 10.18
30-44 12.80 12.27
45-59 23.08 20.51
60-69 39.07 35.26
70-79 61.99 54.70
80+ 108.35 103.70
Overall 10.84 10.43
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Table 17: Percentage change in burden of measles in Sudan in 2002 when using Ghana 
disability weights, by age and sex: 
 
Age group Males Females 
Less than 4    0.38 0.38
5-14 2.19 2.21
15-29 1.37 1.35
30-44 - -
45-59 - -
60-69 - -
70-79 - -
80+ - -
Overall 0.73 0.73
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Table 18: Percentage change in burden of wasting in Sudan in 2002, when using Ghana 
disability weights, by age and sex: 
Age group Males  Females  
Less than 4     38.42 40.59 
5+ - - 
Overall 38.42 40.59 
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Table 19: Percentage change in burden of low birth weight in Sudan in 2002, when using 
Ghana disability weights, by age and sex: 
 
Age group Males  Females  
Less than 4   0.01 0.01 
5+ - - 
Overall 0.01 0.01 
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Table 20: Percentage change in burden of maternal hemorrhage in Sudan in 2002, when 
using Ghana disability weights, by age and sex: 
 
Age group Percentage change 
0 – 4 - 
5 – 14 0.83 
15 – 29 1.29 
30 – 44 1.41 
45 – 59 0.90 
60 – 69 0.05 
70 – 79 0.06 
80+ 0.17 
Overall 1.23 
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Table 21: Percentage change in burden of Diabetes Mellitus in Sudan in 2002, when 
using Ghana disability weights, by age and sex: 
 
Age group Males Females 
Less than 4    11.81 10.84 
5-14 -49.13 -27.66 
15-29 -1.57 24.10 
30-44 8.53 3.36 
45-59 16.69 13.48 
60-69 -1.65 6.32 
70-79 -1.65 2.35 
80+ -71.63 -44.39 
Overall 8.91 8.47 
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Table 22: Percentage change in burden of road traffic accidents in Sudan in 2002, when 
using Ghana disability weights, by age and sex: 
 
Age group Males Females 
Less than 4     -3.88 -4.38
5-14 -2.77 -3.10
15-29 -2.26 -2.72
30-44 -2.88 -4.32
45-59 -3.15 -3.42
60-69 -3.74 -3.76
70-79 -3.17 -1.13
80+ -0.79 -1.01
Overall -2.6702 -5.47943
  
 
 
 
 
CHAPTER FOUR 
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DISCUSSION 
 
NATIONAL INCIDENCE AND MORTALITY ESTIMATES 
Malaria 
The incidence and mortality calculated in this study exceeded that reported from 
health facilities (34) because under-reporting was taken into account using a method 
derived from that used to quantify malaria burden in two districts in southern Ghana 
(88). The under-reporting fraction calculated was in agreement with the finding that less 
than 20% of presumed malaria cases in sub-Saharan Africa are reported to the formal 
health system (89). It was also close to the underreporting factor found in southern 
Ghana (88). The number of cases and deaths also exceeded the prior estimates reported 
in the GBD 2002 (33). This could be due to the different methods of calculation. The age 
distribution was also different with most cases and deaths occurring in 5 – 14 yrs age 
group, rather than the 0 – 4 yrs group in the prior estimates. This was most probably the 
result of the computer modeling process because the preliminary estimates reported most 
of the cases in the 0 – 4 group. However the age group 0 – 14 yrs in both sources of 
estimates still carried the highest incidence and mortality. 
 
Measles 
The incidence and mortality rates were higher than those of the GBD estimates in 
spite that both studies used the same method. The birth cohort used in the study was 
probably increased by the high crude birth rate used for southern Sudan. Mortality was 
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higher because the case fatality ratio used in this study exceeded the maximum CFR 
reported in measuring the global burden of measles (27).  
Another set of estimates have been developed using dynamic models (89). These are 
claimed to be more reliable since they account for age specific attack rates and population 
immunity. However the models are complex and require more data than the static model 
used in this study. 
 
Protein energy malnutrition 
The calculation and the application of the trend in protein energy malnutrition were 
main steps in the analysis of its burden. The trend calculation for underweight was similar 
to that conducted for Sudan in a previous study (90), but in this study, the prevalence was 
adjusted for seasonal variation. That is why unlike the other study, the prevalence showed 
a declining trend. 
The total number of incident cases compared well with the GBD prior estimates (33), 
probably due to the use of similar data sources. Even after calculation and application of 
trend, the prevalence in 2002 was very close to the 2000 prevalence reported in the MICS 
(28) and used in the GBD 2000 (34). However mortality differed not only in numbers but 
also in age distribution. This was probably an effect of the computer modeling process. 
 
Low birth weight 
The prior estimates of the number of incident cases of disabling sequelae (33) 
exceeded that of the study while the opposite occurred regarding the number of deaths. 
This was most probably due to the different calculation methods and the different data 
sources used.  
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Maternal hemorrhage 
The prior estimates for the number of incident cases and deaths (33) also exceeded 
those of the study probably due to the different calculation methods. Occurrence of cases 
and deaths of maternal hemorrhage beyond the reproductive age group of 15 – 49 years 
is an effect of computer modeling. The estimates can be corrected using expert opinion 
to limit the results to the reproductive age group.   
Diabetes mellitus 
The incidence followed the age and sex distribution of the preliminary prevalence 
estimates. When the number of cases and deaths are compared to the prior GBD 
estimates (33), they are found to be lower than the latter. The GBD use the same source 
of data used in this study for northern Sudan. However in this analysis, the overall 
prevalence was lower than that for northern Sudan because of the relatively low 
prevalence assumed for southern Sudan. On the other hand, the number of deaths 
calculated in this analysis was higher than that of the GBD probably due to the different 
calculation methods. 
Road traffic accidents 
Road traffic accidents had the lowest incidence and mortality of all the diseases. The 
rates were probably underestimated due to the complete dependence on officially 
reported cases. However no population based studies were found. As expected the 
numbers of cases and deaths reported in the GBD prior estimates for Sudan far exceeded 
those of the study. 
 
THE ROLE OF COMPUTER MODELING 
In spite that DISMOD ensured that the estimates produced were internally consistent 
and therefore more valid, unexpected results were obtained in the case of malaria and 
 Discussion 
 101
maternal hemorrhage. This was also pointed out in a validation study that compared the 
results of DISMOD and another software with measurements from a high quality 
empirical data set. Large discrepancies and unrealistic results were obtained. These were 
attributed to data inaccuracies or past disease trends. The validation study acknowledged 
the importance of judgement and expert knowledge in the revision of estimates from the 
disease modeling software (91).  
DISABILITY ADJUSTED LIFE YEARS 
The age and sex distribution of DALYs per 1000 population in most diseases 
followed the age and sex distribution in the final incidence and mortality estimates. 
However in the case of road traffic accidents, the burden shifted to earlier age groups 
probably due to the loss of more YLLs per one death in the younger age groups than in 
older ones. In the case of maternal haemorrhage, in spite that most of the incidence and 
mortality were in the reproductive age group, the second peak in burden per 1000 
population after the age of 59 years was observed and was due to the relatively small 
denominator after 59 years. 
Effective comparison between the total DALYs lost due to each disease as calculated 
in this study and the total DALYs reported in the GBD prior estimates (33) was hindered 
by the application of age weighting and discounting to the latter. The prior estimates were 
lower than the study estimates for malaria, measles, protein energy malnutrition and low 
birth weight because the epidemiological estimates had the same difference. For diabetes 
mellitus the differences in mortality and the effect of age weighting and discounting led 
to the fact that the prior estimates (33) were also lower than the study estimates. 
However in the case of road traffic accidents and maternal hemorrhage, the wide 
difference in epidemiological estimates made the prior estimates higher than the study 
estimates in spite of age weighting and discounting. 
The rank order of the diseases did not differ much between males and females. This 
was because in most of the diseases under study, absence of sex difference was assumed, 
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while in others the estimates were almost equal for both sexes. In road traffic accidents 
the burden was much higher in males than in females, but it was still very low compared 
to the other diseases. The domination of the burden by childhood conditions may 
partially be due to the absence of age weighting and discounting. That was why the 
application of age weighting and discounting has been recommended (2). As expected in 
a developing country, the burden of non communicable diseases and injuries was less 
than that of communicable diseases and childhood illnesses included in the study. 
However the relative importance of non communicable diseases and injuries could not be 
concluded from this study because the rest of the conditions have not been assessed yet. 
No generalization could be made beyond this list of diseases. If a full analysis had been 
conducted it might have appeared that non communicable diseases and injuries rank 
higher than other communicable conditions or maternal and perinatal and nutritional 
conditions. Moreover, road traffic accidents burden is expected to be an underestimate 
because of the use of official reports.  
In females, the fact that maternal haemorrhage accounted for a low burden could be 
due to the limited age range affected by the condition. Although low birth weight and 
protein energy malnutrition also affect a limited age range, their action early in life leads 
to loss of more YLLs than would occur in maternal hemorrhage. 
The rank order of the diseases in this way should be interpreted with caution. This is 
because the disease categories are mutually exclusive. The sequelae of malaria do not 
include low birth weight or protein energy malnutrition and the sequelae of measles do 
not include protein energy malnutrition. However, since malaria is a risk factor for low 
birth weight (92), the burden of low birth weight necessarily includes low birth weight 
resulting from malaria. Therefore the burden of malaria extends beyond the reported 
burden to include part of the burden of low birth weight. In fact the overall burden of 
malaria might exceed that of low birth weight. This argument is supported by the finding 
that malaria more than doubled all cause mortality in children less than five years (93). 
The same argument applies to measles as a risk factor for protein energy malnutrition. 
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The choice of a disease as a priority for action should therefore account for the mutually 
exclusive nature of the diseases categories and the part of the disease burden attributable 
to other diseases in the list.  
The difference in the rank order of diseases using the prior estimates of the GBD (33) 
was expected since different calculation methods, different data sources and the use of 
age weighting and discounting led to large differences between the DALY estimates for 
the study and prior DALY estimates of the GBD (33). 
The difference in the rank order between different age groups was also expected 
because some diseases are most frequent in certain age groups. It also differed between 
males and females partly due to the interference of maternal hemorrhage as a condition 
exclusive to females and partly due to the sex difference in the burden of road traffic 
accidents. 
The slight change in the rank order when using DALYs compared to YLLs only was 
due to the fact that for most of the diseases selected for the study, the burden of 
mortality was predominant. Therefore the addition of disability burden did not make a 
significant change. However it cannot be concluded that the burden of mortality alone is 
enough to assess disease burden because this is a limited diseases list and different results 
may be obtained if a full analysis is conducted. In studies with a full disease burden 
analysis (17,18,22-25), more significant changes in the rank order of the diseases were 
observed. 
 
Comparison of the results with the results of other countries was hindered by the use 
of other summary measures of population health in measurement of the disease burden 
in some countries, the use of discounting and age weighting for DALYs used by the 
other countries, the different years of assessment and the different methods of 
categorization of the diseases. In general, group I diseases predominated the burden as in 
developing countries (18,22). The results contrasted with those of developed countries 
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(17,24,25) where most of the burden was attributed to non communicable diseases and 
injuries. The regional estimates of DALYs for the same diseases showed similar results 
except for road traffic accidents which ranked second in the group and protein energy 
malnutrition ranking fifth (26). 
SENSITIVITY ANALYSIS 
The decision about which set of disability weights is to be used is important because 
the disability weights are the most subjective part of the burden of disease analysis. Their 
being most approximate to local societal preferences encourages decision makers to use 
the results. Ghana disability weights were used in this analysis because they were 
developed in a neighboring African country with similar conditions. As expected their 
effect was largest on the disease with a large disability burden; Protein Energy 
Malnutrition. The effect was the least for the diseases with predominant mortality burden 
except for malaria and diabetes mellitus. In these diseases, the difference in the disability 
weights of the GBD and of Ghana for these diseases was large. 
For each disease, the effect of using Ghana disability weights varied between males 
and females and between the different age groups. This variation between the age groups 
is the widest in the case of malaria probably because of the high disability weight given to 
malaria in the Ghana set. This is expected to affect the rank order of malaria and diseases 
with a similar characteristic within the different age groups 
In spite that the Ghana disability weights were expected to be the most approximate 
to Sudanese societal preferences, their use was constrained by the different disease 
categorization and case definitions used in their development.  
Age weighting and discounting reduce the disease burden. The amount of reduction 
varies between the diseases and depends on the age group most affected by the disease. 
Sensitivity to age weighting and discounting is better examined by the difference in the 
rank order of the disease categories with and without them. This is more informative if a 
full analysis is made. A small number of diseases that do not represent the full disease list 
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regarding age group most affected would not give valid information to decide whether to 
apply them or not. That was why sensitivity analysis to age weighting and discounting was 
not attempted in this study. 
LIMITATIONS OF THE STUDY 
This study was based on collection and processing of secondary data, which created 
uncertainty in the estimates. This problem was common to all national burden of disease 
studies but in varying degrees (17, 18, 22-25). The uncertainty in this study came from the 
following sources: 
The data sources 
Bias 
Bias resulting from methodological issues in the studies used was carried on to the 
calculated estimates. In some studies such flaws could not have been evident because 
some aspects of the methodology were not reported. Where bias was evident the studies 
were resorted to only where no other sources could be found. The bias in the studies 
cannot be quantified and therefore cannot be expressed as uncertainty limits. 
Bias from non representativeness was the most evident type. The data used ranged 
from health facility based case studies to nationally representative population based 
studies. Health facility based case studies are not representative of the population 
concerned even if sample sizes are adequate. Some population based studies and NGO 
surveillance systems were localized and did not represent all the country. Even some 
national surveys failed to cover the whole country due to inaccessibility of some areas. 
Some estimates were borrowed from studies in neighboring African countries, and one 
of the studies used was in Finland.  However non representative and non local studies 
were resorted to only where no local estimates could be found or were too unreliable to 
use.  
 Discussion 
 106
Time of  study 
Not all the studies used related to 2002. This could have affected the validity of the 
results because their use was based on the assumption of a stable epidemiological and 
demographic status. Except for protein energy malnutrition, no reliable time series data 
could be found to estimate trends in the diseases epidemiology. However in the case of 
road traffic accidents, a study showed that the incidence of serious injury was stable (95). 
Using old data may lead to overestimation or underestimation of the burden of disease 
with declining or rising trends respectively. 
Case definitions 
Although studies collected for use essentially had to have the same case definitions as 
those used developing the disability weights, this rule was violated in four situations: 
1. Case definitions were not matched with those of the Ghana disability 
weights because the study used disease categories and sequelae of the GBD. 
These were different from those used by The Ghana health assessment 
team.  
2. In estimating the proportion of severe anaemia from malaria, all the studies 
found used the same case definition for severe anaemia for all population 
groups. The GBD defined severe anaemia differently for pregnant women, 
children and non pregnant adults. 
3. In estimating the incidence of maternal hemorrhage, the proportion 
reported in the SMS was based on subjective assessment of the respondent 
of the occurrence of heavy bleeding. Self reporting of hemorrhage 
experience was found to overestimate the incidence of these diseases (29). 
However this survey was resorted to because it was nationally representative 
and population based, and because other studies were case studies that 
reported maternal haemorrhage as a hospital proportion. The lack of an 
objective method to measure the amount of blood lost and the different 
case definitions used in different studies has been a continuous limitation in 
measuring the burden of maternal haemorrhage (29). 
4. Studies reporting the proportions of diabetes mellitus sequelae did not 
report case definitions. They were used because they were the only sources 
of such information. 
 Discussion 
 107
The consequences of using a data source with a non matching case definition is that 
false positive cases (with the GBD definitions as gold standard) will be included or false 
negative cases excluded, leading to over or underestimation of the disease burden 
respectively. 
Different study populations 
Some estimates were found for only certain age groups such as neurological sequelae 
from malaria and prevalence of diabetes mellitus. The estimates were generalized from 
these groups with little or no supporting evidence. This was resorted to because of the 
lack of studies on the other age groups. Findings from northern Sudan were generalized 
to southern Sudan in the same way. 
Uncertainty from indirect methods 
Simple indirect methods were used to calculate the case fatality rate of road traffic 
accidents, prevalence of diabetes in the age group 0 – 14 years and 15 – 24 years and 
incidence of wasting. More complicated indirect methods were used to calculate the 
incidence of malaria, measles, severe anaemia resulting from maternal hemorrhage and 
incidence of stunting and developmental disability from malnutrition. These methods 
combined information from different sources and therefore combined multiple 
uncertainties. They also used assumptions to fill information gaps and this added to the 
uncertainty. 
Uncertainty from assumptions 
The methods designed or adopted from the GBD involve assumptions where no 
direct evidence or no information was available. The assumptions therefore carry their 
own uncertainty. However these assumptions were revised and endorsed by experts. 
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Uncertainty from disability weights 
Disability weights reflect societal preferences. In spite of the extensive analysis done 
in the GBD to ensure that the disability weights developed were highly reliable, their 
method of development was subjective and therefore they carry an unquantifiable level of 
uncertainty. Ghana disability weights are expected to be closer to the local social 
preferences than the GBD disability weights. 
Uncertainty analysis 
An uncertainty analysis was not conducted in this study due to difficulties in obtaining 
necessary input and technical difficulties associated with the analysis. 
DATA GAPS REVEALED 
There were no reliable sources of all cause mortality and cause specific mortality. 
No nationally representative reliable source of malaria or measles incidence exists. 
Except for measles, longitudinal population based studies of the natural history of the 
diseases could not be identified. They are the most reliable source of case fatality and 
remission rates as well as disability proportions and the average duration of the diseases 
(2). National maternal hemorrhage morbidity data was derived from self reported 
morbidity over a long recall period. There were no local population based studies of 
incidence and case fatality of maternal hemorrhage with ascertainment of the morbid 
conditions using a standard case definition as in the MOMA study. There was no wider 
scale research on the sequelae of road traffic accidents. 
NEW ADDITIONS IN THIS STUDY 
This study is the first local assessment of the burden of the selected diseases in Sudan. 
As part of the GBD revisions for the year 2002, country specific estimates were 
developed (4). Except for measles, protein energy malnutrition and diabetes mellitus, 
these estimates were developed by indirect methods from regional estimates. For diseases 
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where country specific data was used in the GBD assessment, more local studies were 
used by this assessment. For measles, more recent population estimates for southern 
Sudan, and estimates from more recent studies on case fatality were used. The age 
distribution of cases was adopted from a local study rather than from the GBD methods. 
In the case of protein energy malnutrition trend was estimated after adjusting some of the 
estimates, and was used to calculate prevalence proportions in 2002. As for diabetes 
mellitus, a more valid national prevalence was calculated when the prevalence obtained 
for northern Sudan was combined with the prevalence expected to apply to southern 
Sudan. Local studies that included postgraduate theses and unpublished studies were 
used to calculate the proportions of disabling sequelae. Local expert opinion was also 
used. 
The study coupled mortality and morbidity in a single estimate for each disease, 
allowing easy comparison between the different diseases. It developed national internally 
consistent epidemiological estimates for the selected diseases, making the maximum use 
of the available data. However the estimates should be considered as initial estimates and 
the methods used should not final; they form a basis for further revisions and 
modifications based on new evidence and further studies. Moreover, even the best 
developed indirect methods should be considered as temporary alternatives for 
information provision. They should not cancel the need to develop high quality health 
information system with high quality data and low under-reporting fractions.   
CONSTRAINTS IN THE STUDY 
The local databases were uncoordinated and some lacked recent research. Some of 
the papers identified through their abstracts were not available in full text and could not 
be reviewed or used. With the lack of resources, experts were consulted separately with 
no consensus process. Technical difficulties with the computer disease modeling and 
uncertainty analysis were faced. 
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CONCLUSIONS 
1. The incidence and mortality rates of each condition were found to vary by age and 
sex in a pattern that reflects that of the original data used to generate them. In the 
case of malaria the computer modeling process altered the pattern observed in the 
original data.   
2. Wide variations were found between the incidence and mortality estimates 
calculated in this study and those calculated by the GBD for Sudan, probably due 
to different calculation methods, different data sources and the application of age 
weighting and discounting in the latter. 
3. For both males and females, low birth weight accounted for the highest burden 
followed by protein energy malnutrition, malaria, measles, Diabetes Mellitus and 
road traffic accidents, with maternal hemorrhage preceding the latter in females. 
4. The age and sex distribution of DALYs per 1000 population followed that of the 
epidemiological estimates in most of the diseases. 
5. The rank order of the diseases varied in the different age groups. 
6. Addition of the burden of disability to the burden of mortality made a slight 
change to the rank order of the diseases under study. 
7. The change in disease burden when using the Ghana disability weights was the 
greatest in diseases with a high disability burden and in those where the difference 
between the Ghana disability weights and the GBD disability weights was large. 
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8. The validity of disease burden estimates was reduced by uncertainties arising from 
bias in the data sources used, steady state assumption, case definitions, different 
study populations, indirect methods, assumptions and disability weights. 
9. The study revealed deficiencies in mortality data, nationally representative data on 
frequency of malaria and measles, valid data on the incidence of maternal 
hemorrhage, and longitudinal population based studies that provide case fatality 
and remission rates as well as disability proportions and the average duration of 
the diseases. 
10. Difficulty in obtaining the data needed, obtaining expert consensus, the use of 
computer modeling and technical difficulties with uncertainty analysis were faced 
during the course of the study. 
11. In-spite of the data deficiencies and constraints faced, it is possible to conduct a  
full burden of disease analysis. 
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C h a p t e r  8  
RECOMMENDATIONS 
1. Further revisions and improvement of the data sources used in development of 
the preliminary epidemiological estimates for the diseases studied. 
2. Conduction of a full analysis of the burden of other important of diseases in 
Sudan. 
3. Conduction of verbal autopsy studies or longitudinal studies as a temporary resort 
to provide more reliable mortality data for the diseases studied. 
4. The vital registration system should be improved to provide the most reliable 
mortality data. 
5. Part of the research efforts should be directed towards population based 
longitudinal studies and national surveys to provide representative incidence of 
measles and malaria and road traffic accidents injures as well as reliable estimates 
of average duration, remission, case fatality and disability proportions for all the 
conditions studied.  
6. More valid estimates of maternal morbidity should be made available in the short 
term by longitudinal population based studies and in the long term by population 
based or health facility based surveillance with minimal under-reporting. 
7. Research should be conducted to update old national estimates of diabetes 
prevalence in Sudan. 
8. Databases in the country should be updated with the most recent research and the 
different data bases available should be coordinated and act with the different 
research institutes to facilitate the obtaining of research results. 
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9. Proper training of researchers in Sudan on measuring the burden of disease using 
the DALY approach including the proper use of the different software available. 
10.  Revision and modification of DISMOD output for the diseases under study by 
experts. 
 
 References 
 114
C h a p t e r  9  
REFERENCES 
1. Murray CJL, Salomon JA., Mathers C. A critical examination of summary 
measures of population health. Bulletin of the World Health Organization 
2000;78(8):981–94. 
2. Mathers CD, Vos T, Lopez AD, Salomon J, Ezzati M, editors. National Burden 
of Disease Studies: A Practical Guide. 2nd ed. Geneva: World Health 
Organization; 2001. 
3. Murray CJL, Lopez, AD, editors. The global burden of disease: a comprehensive 
assessment of mortality and disability from diseases, injuries and risk factors in 
1990 and projected to 2020. Cambridge: Harvard University Press; 1996. (Global 
burden of disease and injury, vol 1) 
4. Mathers C, Bernard C, Iburg KM, Inoue M, Ma Fat D, Shibuya K et al. Global 
Burden of Disease in 2002: data sources, methods and results. World Health 
Organization, Global Programme on Evidence for Health Policy. Discussion 
Paper no. 54. 2003;[118]. Available at:   
www3.who.int/whosis/burden/gbd2000docs/paper54.pdf. Accessed July 12, 
2004. December 2003. 
5. Murray CJL, Frenk J. A framework for assessing the performance of health 
systems. Bulletin of the World Health Organization 2000;78(6):717–31. 
6. Hyder AA., Morrow RH. Disease burden measurement and trends. In: Merson 
MH, Black RE, Mills AJ, editors. International public health: Diseases, programs, 
systems and policies. Maryland: Aspen Publishers Inc.; 2001. p. 1 – 52. 
7. Mathers CD, Stein C, Ma Fat D, Rao C, Inoue M, Tomijima N et al. Global 
Burden of Disease 2000: Version 2 methods and results. World Health 
Organization GPE Discussion Paper number 50. 2002;[59]. Available at: 
 References 
 115
www3.who.int/whosis/burden/gbd2000docs/paper50.pdf. Accessed November 
23, 2002. 
8. Murray CJL, Lopez AD. Alternative projections of mortality and disability by 
cause 1990 – 2020: Global burden of disease study. Lancet 1997;349:1498 -504. 
9. Murray CJL, Lopez AD. Global mortality, disability and the contribution of risk 
factors: Global burden of disease study. Lancet 1997;349:1436–42. 
10. Murray CJL, Ferguson BD, Lopez A, Guillot M, Salomon JA, Ahmad O. 
Modified Logit life table system: Principles, Empirical Validation and 
Application. GPE discussion paper no. 39. [13]. Available at: 
www3.who.int/whosis/burden/gbd2000docs/paper39.pdf. Accessed November 
23, 2002. 
11. Lopez A, Ahmad O, Guillot M, Inoue M, Ferguson BD, Salomon JA. Life tables 
for 191 countries in 2000, data, methods and results. GPE discussion paper 40. 
Evidence and information for policy, World Health Organization. 2001;[447]. 
Available at:  www3.who.int/whosis/burden/gbd2000docs/paper40.pdf. 
Accessed October 31, 2003 
12. Salomon JA, Murray CJL. Compositional models for mortality by age, sex and 
cause. Global Program on Evidence for Health Policy. Discussion Paper no. 11. 
[8]. Available at: www3.who.int/whosis/burden/gbd2000docs/paper11.pdf. 
Accessed November 23, 2002. 
13. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: 
Global burden of disease study. Lancet 1997;349:1269–76. 
14. Coale A.J, Demeney P, Vaughan B. Regional model life tables and stable 
populations. New York: Academic press, Inco; 1983. 
15. DISMOD II [computer software]. Version 1.01. Erasmus University, Barendregt 
YJ; 2001.  
16. Murray CJL, Lopez AD. Regional patterns of disability-free life expectancy and 
disability-adjusted life expectancy: Global burden of disease study. Lancet 
1997;349:1347–1352. 
 References 
 116
17. Mathers C, Vos T, Stevensons C, Begg SJ. The burden of disease and injury in 
Australia. Bulletin of the World Health Organization 2001;79(11):1076–84. 
18. Ghana Health Assessment Team. A quantitative method for assessing the health 
impact of different diseases in less developed countries. Int J  Epid 1981;10:73–
80. 
19. Salomon JA, Mathers C, Murray CJL, Ferguson B. Methods for life expectancy 
and healthy life expectancy uncertainty analysis. Global Program on Evidence 
for Health Policy working Paper number 10. World Health Organization. 
2001[18]. Available at: 
www3.who.int/whosis/burden/gbd2000docs/paper10.pdf. Accessed November 
23, 2002. 
20. Hyder AA, Rotlant G, Morrow RH. Measuring the burden of disease: Healthy 
Life-Years. Am J Pub Health 1998;88(2):196–202. 
21. Hyder A, Morrow RH. Steady state assumptions in DALYs: effect on estimates 
of HIV impact. J Epid Comm Health 1999;53:43–45. 
22. Hyder AA, Morrow RH. Applying burden of disease methods in developing 
countries: a case study from Pakistan. Am J Pub Health 2000;90:1235–40. 
23. Lozano R, Murray CJL, Frenk J, Bobadilla JL. Burden of disease assessment and 
health system reform: results of a study in Mexico. J Int Dev 1995;7(3):555-63.  
24. Vos T, Beggs S. Victorian Burden of Disease Study: morbidity. Melbourne, 
Department of Human Services, 2000. 
25. Bradshaw D, Groenewald P, Laubscher R., Nannan N, Nojilana B, Norman R et 
al. Initial burden of disease estimates for South Africa 2000. 2003[102]. Available 
at: www.mrc.ac.za/bod/initialbodestimates.pdf. Accessed April 29, 2004.  
26. DALY estimates by sex, age, and cause for six WHO regions in 2002. World 
Health Organization. 2003[53]. Available at 
www3.who.int/whosis/burden/estimates/2002Rev/2002Revregion/DALY620
02Rev.zip.  
 References 
 117
27. Stein CE, Birmingham M, Kurian M, Duclos P, Strebel P. The global burden of 
measles – a model that uses country specific indicators. J Inf Dis 2003;187(Suppl 
1):8–14. 
28. Global burden of malnutrition in the year 2000. [11]. Available at: 
www3.who.int/whosis/burden/gbd2000docs/Malnutrition.zip   .  Accessed July 
12, 2004.  
29.  Dolea C, AbuZahr C, Stein C. Global burden of maternal hemorrhage in the 
year 2000. 2003[16]. Available at: 
www.who3.int/whosis/burden/gbd2000docs/Mat_haemorrhage.zip . Accessed 
September 29, 2004.  
30. Elbagir MN, Eltom MA, Elmahadi EMA, Kadam IMS, Berne C. A population-
based study of the prevalence of diabetes and impaired glucose tolerance in 
adults in northern Sudan. Diabetes Care 1996;19(10):1126–28. 
31. Wild S, Roglic G, Secree R, Green A, King H. Global burden of diabetes 
mellitus in the year 2000. [28]. Available at: 
www.who3.int/whosis/burden/gbd2000docs/diabetes.zip . Accessed  July 12, 
2004.   
32. Begg S, Tomijima N. Global burden of injury in the year 2000: an overview of 
methods. [22]. Available at: 
www.who3.int/whosis/burden/gbd2000docs/Injury.zip. Accessed July 12, 2004.  
33. Prior estimates of incidence, prevalence, mortality and average duration for 
Sudan in 2002. Global Program on Evidence for Health Policy, World Health 
Organization. (Unpublished data). 
34. Sudan Federal Ministry of Health. Annual Statistical Report 2002. Khartoum: 
Federal Ministry of Health; 2003. 
35. Sudan Federal Ministry of Health. Multiple Indicators Cluster Survey 2000. 
Khartoum: Ministry of Health; 2001. 
36. Sudan Federal Ministry of Health. National Safe Motherhood Survey 1999. 
Khartoum: Ministry of Health; 2001. 
 References 
 118
37. Sudan Ministry of Finance & National Economy. Population projections for 
Sudan 1993 – 2018. Khartoum: Central Bureau of Statistics; 1996. 
38. Ministry of Economic and National Planning, Sudan, Institute for Resource 
Development/ Macro International Inc. Sudan Demographic and Health Survey 
1989/1990. Maryland, USA: Macro International Inc.;1991. 
39. Federal Ministry of Health, Pan Arab Project for Child Development. Sudan 
Maternal and Child Health Survey 1992/1993. Khartoum: Federal Ministry of 
Health; 1995. 
40. UNICEF/OLS. Multiple Indicators Cluster Survey for Southern Sudan. 2000. 
[108]. Available at: 
http://www.childinfo.org/MICS2/newreports/sudan2/sudan2.htm. Accessed 
October 18, 2003. 
41. Microsoft Excel [computer software]. Version 10.2614.2625. Microsoft 
corporation; 2002.  
42. Ibrahim SM. Decisive assessment of diagnostic staining methods of malaria in 
eight public and private laboratories, Khartoum area. Operational Research on 
Tropical Diseases: Final Report Summaries 1992 – 2000. Cairo, Egypt; 2003. p. 
44 – 45. 
43. Malik E M. Epidemiological, clinical and laboratory aspects of malaria among 
children presented with fever in urban area during low transmission season, 
Sudan. Eastern Mediterranean health journal (in press). 
44. Sudan Federal Ministry of Health. Annual Statistical Report 2000. Khartoum: 
Federal Ministry of Health; 2001. 
45. UNICEF. End Decade Assessment, Multiple Indicator Cluster Surveys: 
Standard tables for Sudan. 2003[82]. Available at: 
http://www.childinfo.org/MICS2/newreports/sudan1/sudantables.pdf.  
Accessed October 18, 2003.   
46. Malaria situation and the progress made in RBM implementation in southern 
Sudan. 2004[25]. Available at: 
 References 
 119
http://www.emro.who.int/rbm/presentations/irn04/South%20Sudan.htm. 
Accessed August 1, 2004. 
47. McCarthy MC, Haberberger RL, Salib AW, Soliman BA, El-Tigani A, Khalid IO, 
Watts DM. Evaluation of arthropod-borne viruses and other infectious disease 
pathogens as the causes of febrile illnesses in Khartoum Province of Sudan. J 
Med Virol 1996;48(2):141-46. 
48. Siddig AA. The use of the insecticide treated bed-nets as a method of malaria 
prevention and control in a Sudanese high seasonal malaria transmission area 
[thesis]. University of Khartoum, 2000. 
49. Malaria epidemiology in Umsalala and Koka villages. Institute of endemic 
diseases, University of Khartoum. Unpublished data. 
50. Creasy A, Hamad A, Elhassan IM, Giha H, Theander TG, Arnot DE. 11 years 
of malaria surveillance and treatment in a Sudanese village highlight unexplained 
variation in disease susceptibility and outbreak severity. Parasitology 2004;129(Pt 
3):263-71 
51. Annual reports of community health workers in Wau, Raja and Malakal, 2001. 
International Rescue Committee. Unpublished data. 
52. Giha AH, El-GhazaliG, Elhasan TM, Eltayib I, Eltahir EM, Baraka OZ et al. 
Clinical pattern of severe P. falciparum malaria in Sudan in an area characterized 
by seasonal and unstable malaria transmission. Trans R Soc Trop Med Hyg 
2005;99(4):243-51.  
53. Zeidan Z, Kojal H, Habour M, Nowary K, Hashim F, Erikson B. 
Clinicoepidemiological features of severe malaria in children in Sudan: hospital 
based prospective study. Eastern Mediterranean Health Journal (in press). 
54. Ataalla N. Pattern of selected haematological changes in malaria infection in 
children in Khartoum state [thesis]. University of Khartoum, Khartoum, Sudan 
1994. 
55. Elhassan A M A. Erythropoeitin level in anaemia due to Plasmodium falciparum 
malaria [thesis]. University of Khartoum, Khartoum, Sudan, 1993. 
 References 
 120
56. Mungala-Odera V, Snow RW, Newton CRJC. The burden of neurocognitive 
impairment associated with Plasmodium falciparum malaria in sub-saharan 
Africa. Am J Trop Med Hyg 2004;71(Suppl 2):64 – 70. 
57. Bondi FS. The incidence and outcome of neurological abnormalities in 
childhood cerebral malaria: a long term follows up of 62 survivors. Trans R Soc 
Trop Med Hyg 1992;86:17–19. 
58. Mustafa OM. Measles: epidemiological, immunological and diagnostic study 
[thesis]. University of Khartoum, Khartoum, Sudan 1999. 
59. Ibrahim SA, Mustafa OM, Mukhtar MM, Saleh EA, El Mubarak HS, Abdallah A 
et al. Measles in suburban Khartoum: an epidemiological and clinical study. Trop 
Med Int Health 2002;7(5):442–9. 
60. Strebel P. Measles case fatality ratios in outbreak settings. Inter-Country Meeting 
on Measles and Rubella Control. Cairo, Egypt; September 2004 
61. UNICEF, Sudan Multiple Indicator Cluster Survey 1995. Khartoum: UNICEF; 
1996.  
62. Karrar ZA, Omer MIA. Morbidity patterns among under-five children in a rural 
community in Sudan. Trop Geog Med 1981;33:75–8. 
63. Spasoff RA. Epidemiologic methods for health policy. New York: Oxford 
University Press; 1999. 
64. Bern C, Nathanail L. Is mid-upper arm circumference a useful tool for screening 
in emergency settings? Lancet 1995;345:631-33. 
65. Rantakallio E, Von Wendt L. Prognosis for low-birth weight infants up to the 
age of 14: a population based study. Dev Med Child Neurol 1985;27(5):655–63. 
66. Prual A, Bouvier-Colle MH, de Bernis L, Breart G. Severe maternal morbidity 
from direct obstetric causes in West Africa: incidence and case fatality rates. 
Bulletin of the World Health Organization 2000,78(5):593–602. 
67. Umbeli T, Abusalab MA. Maternal mortality at Omdurman Maternity Hospital 
and Saudi Maternity Hospital 1998 – 2001. Proceedings of the 19th Congress of 
Obstetrics and Gynaecology. Phase II and Phase III of the Project of Women’s 
 References 
 121
sexual and reproductive rights; 2003 Mar 5-6; Khartoum, Sudan. Khartoum: 
Sudan; 2003.  
68. Mohammed A A, Abdelrahiem S I, Elnour M H, Abdelfattah A I. Maternal 
mortality in Kassala state. Proceedings of the 19th Congress of Obstetrics and 
Gynaecology. Phase II and Phase III of the Project of Women’s sexual and 
reproductive rights; 2003 Mar 5-6; Khartoum, Sudan. Khartoum: Sudan; 2003.  
69. Elsanousi M et al. Maternal mortality at Wad Medani Obstetrics and 
Gynaecology Teaching Hospital in 5 years 1998 - 2002. Proceedings of the 19th 
Congress of Obstetrics and Gynaecology. Phase II and Phase III of the Project 
of Women’s sexual and reproductive rights; 2003 Mar 5-6; Khartoum, Sudan. 
Khartoum: Sudan; 2003.  
70. Dafaalla S E, El-Agib F H, Bushra G O. Matenal mortality in a teaching hospital 
in Sudan. Saudi Medical Journal 2003, 24 (4): 369 – 372. 
71. Hassanein O M. Summary of the Maternal mortality in Elobeid General Hospital 
1974 - 1976. Arab Medical Bulletin, 1985, 5-6(7): 24. 
72. Omer AA. Maternal mortality in Juba Teaching Hospital 1974 - 1976. Arab 
Medical Bulletin 1985;5-6(7):25-6. 
73. Abu Median A K. Summary of the paper of maternal mortality in Kosti Hospital 
1977 - 1981. Arab Medical Bulletin 1985;5-6(7):27. 
74. AbouZahr C. Antepartum and postpartum haemorrhage. In: Murray CJL, editor. 
Health dimensions of sex and reproduction: the global burden of sexually 
transmitted diseases, HIV, maternal conditions, perinatal disorders, and 
congenital anomalies. Cambridge: Harvard University Press; 1998. (Global 
Burden of disease and Injury, vol 1). 
75. Mohammed S H. Risk factors and maternal morbidity and mortality of primary 
postpartum haemorrhage in Omdurman Maternity Hospital [thesis]. University 
of Khartoum 2004. 
76. Abdalla A K. Prevalence of anaemia in pregnanat ladies presenting to antenatal 
care clinics in Khartoum state [thesis]. University of Khartoum 1996. 
 References 
 122
77. Prevalence of Diabetes in Africa. [1]. Available at: www.eatlas.idf.org. Accessed  
August 23, 2004. 
78. Elamin A, Ghalib M, Eltayeb B, Tuvemo T. High incidence of Type I Diabetes 
Mellitus in Sudanese children 1991-1995. [7]. Available at: 
www.arabdiabetes.org/arab_countries/sudan/7.htm. Accessed  September 7, 
2004.   
79. Karim A, Ogbeide DO, Siddiqui S, Al-khalifa IM. Prevalence of diabetes mellitus 
in a Saudi community. Saudi Med J 2000; 21(5):438–42. 
80. Kirkwood B, Smith P, Marshall T, Prost A. Relationships between mortality, 
visual acuity and microfilarial load in the area of the Onchocerciasis Control 
Programme. Trans R Soc Trop Med Hyg 1983;77(6):862-8. 
81. Shibuya K, Bernard C, Ezzati M, Mathers CD. Global burden of onchocerciasis 
in the year 2000: summary of methods and data sources. [25]. Available at: 
www3.who.int/whosis/burden/gbd2000docs/Onchocerciasis.zip. Accessed 
April 29,2004. 
82. Elbagir MN, Eltom MA, Mahadi EO. Pattern of long-term complications in 
Sudanese insulin-treated diabetic patients. Diabetes Res Clin Prac, 1995;30:59–
67. 
83. Mohammed EAA. Diabetic septic foot lesions in Khartoum [thesis]. 
University of Khartoum 1999. 
84. Ahmed H B M. Assessment of Diabetic Patients with Diabetic foot lesions 
attending the surgical Department of Jabir Abu Eliz Diabetes CentreIn relation 
to amputation in the Period 1.9.2002 – 30.11.2002 [thesis]. University of 
Khartoum 2003. 
85. Abdel Aaty M A. The vascular status of the diabetic foot: evaluation and 
outcome [thesis]. University of Khartoum 2003. 
86. Wuheb A A. Pattern and casualty management of road traffic accidents in 
Khartoum Teaching Hospital [thesis]. University of Khartoum 1997. 
 References 
 123
87. Annual traffic report 2002. General Traffic Directorate, Ministry of Interior. 
2003. 
88. Agyepong IA, Kayonda JK. Providing practical estimates of malaria burden for 
health planners in resource poor countries. Am J Trop Med Hyg 2004;71(Suppl 
2):162–7.  
89. Breman JG. The ears of the hippopotamus: Manifestations, determinants and 
estimates of the malaria burden. Am J Trop Med Hyg 2001;64(Suppl 1,2):1–11. 
90. Miller MA. Introducing a novel model to estimate national and global measles 
disease burden. Int J Inf Dis 1999;4:14–20. 
91. De Onis M, Blossner M, Borghi E, Frongillo E, Morris R. Estimates of global 
prevalence of childhood underweight in 1990 and 2015. JAMA 
2004;291(21):2600–06. 
92. Kruijshaar ME, Barendregt JJ, Hoeymans N. The use of models in the 
estimation of disease epidemiology. Bulletin of the World Health Organization 
2002;80:622–28. 
93. Guyatt HL, Snow RW. Malaria in pregnancy as an indirect cause of infant 
mortality in sub-saharan Africa. Trans R S Trop Med Hyg 2001;95:569-76. 
94. Snow RW, Korenromp EL, Gouws E. Pediatric mortality in Africa: Plasmodium 
falciparum malaria as a cause or risk? Am J Trop Med Hyg 2004;71(Suppl 2):16–
24. 
95. Ahmed M A. Statistical study on road traffic accidents in the 3 towns [thesis]. 
University of Khartoum 1977. 
 
 annex A: Method used in calculating the completeness of death registration in males and females aged five 
years and above 
 124
 
ANNEX A: METHOD USED IN CALCULATING THE COMPLETENESS OF 
DEATH REGISTRATION IN MALES AND FEMALES AGED FIVE YEARS 
AND ABOVE 
Brass Growth – Balance method: 
Nx = population at exact age x 
Nx+ = population aged x and over. 
Dx+ = deaths at age x and over. 
Dx+/Nx+ = Partial death rate. 
Nx/Nx+ = Partial birth rate. 
X1 = average Dx+/Nx+ for x = 5,10,15,20 
X2 = average Dx+/Nx for x = 25,30,35,40. 
Y1 = average Nx/Nx+ for x = 5,10,15,20. 
Y2 = average Nx/Nx+ for x = 25,30,35,40. 
K = Y2 – Y1 
        X2 – X1 
Completeness of death registration = 1/K 
The calculated numbers are shown in the following tables: 
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Table 23: Calculation of parameters needed for calculating overall completeness of 
registration of deaths aged more than 4 years in Sudan in 2002 
Age  
Registered 
deaths 
Reported  
population 
Age 
X Nx Nx+ Dx+ Dx+/Nx+ Nx/Nx+ 
0 5267 5207725.538 5 520772.6 27558498 9790 0.000355 0.018897
5 452.5 4571224.297 10 457122.4 22987274 9337.5 0.000406 0.019886
10 452.5 4134543.887 15 413454.4 18852730 8885 0.000471 0.021931
15 666.5 3781893.585 20 378189.4 15070836 8218.5 0.000545 0.025094
20 666.5 3184195 25 318419.5 11886641 7552 0.000635 0.026788
25 799.75 2548360.644 30 254836.1 9338281 6752.25 0.000723 0.027289
30 799.75 2071787.231 35 207178.7 7266493 5952.5 0.000819 0.028512
35 799.75 1723692.658 40 172369.3 5542801 5152.75 0.00093 0.031098
40 799.75 1439032.237       
45+ 4353 4103768.588       
Total 15057 32766223.66       
 
Table 24: Parameters used to calculate death registration completeness in Sudan in 2002 
X1 0.000445 
X2 0.000777 
Y1 0.021452 
Y2 0.028422 
K  20.97508 
Death registration completeness in the reporting 
states of Sudan 2002 0.047676 
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Table 25: Calculation of parameters needed for calculating the completeness of 
registration of male deaths aged more than 4 years in Sudan in 2002 
Age 
Registered  
deaths 
Reported   
population 
Age  
X 
Nx Nx+ Dx+ Dx+/Nx+ Nx/Nx+ 
0 2961 2659707.314 5 265970.7 13845939 5301 0.000383 0.019209 
5 259.5 2326428.95 10 232642.9 11519510 5041.5 0.000438 0.020196 
10 259.5 2096723.526 15 209672.4 9422786 4782 0.000507 0.022252 
15 295.5 1946858.939 20 194685.9 7475928 4486.5 0.0006 0.026042 
20 295.5 1643048.252 25 164304.8 5832879 4191 0.000719 0.028169 
25 383.5 1283477.691 30 128347.8 4549402 3807.5 0.000837 0.028212 
30 383.5 999925.6275 35 99992.56 3549476 3424 0.000965 0.028171 
35 383.5 816533.4662 40 81653.35 2732942 3040.5 0.001113 0.029877 
40 383.5 695666.6871       
45+ 2657 2037275.78       
total 8262 16505646.23       
 
Table 26: Parameters used to calculate male death registration completeness in Sudan in 
2002 
X1 0.000482 
X2 0.000908 
Y1 0.021925 
Y2 0.028607 
K  15.68267 
Death registration completeness in the reporting states of Sudan 2002 0.063765 
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Table 27: Calculation of parameters needed for calculating the completeness of 
registration of female deaths aged more than 4 years in Sudan in 2002 
Age 
Registered  
deaths 
Reported   
population 
Age  
X 
Nx Nx+ Dx+ Dx+/Nx+ Nx/Nx+ 
0 2306 2548018.224 5 254801.8 13712559 4489 0.000327 0.018582 
5 193 2244795.348 10 224479.5 11467764 4296 0.000375 0.019575 
10 193 2037820.36 15 203782 9429944 4103 0.000435 0.02161 
15 371 1835034.646 20 183503.5 7594909 3732 0.000491 0.024161 
20 371 1541146.749 25 154114.7 6053762 3361 0.000555 0.025458 
25 416.25 1264882.953 30 126488.3 4788879 2944.75 0.000615 0.026413 
30 416.25 1071861.603 35 107186.2 3717018 2528.5 0.00068 0.028837 
35 416.25 907159.1914 40 90715.92 2809858 2112.25 0.000752 0.032285 
40 416.25 743365.5499       
45+ 1696 2066492.808       
Total 6795 16260577.43       
 
Table 28: Parameters used to calculate female death registration completeness in Sudan 
in 2002. 
X1 0.000407 
X2 0.000651 
Y1 0.020982 
Y2 0.028248 
K  29.85162 
Death registration completeness in the reporting states of 
Sudan 2002 0.033499 
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ANNEX B: KEYWORDS USED IN THE SEARCH OF ELECTRONIC 
DATABASES 
1. Malaria + 
a. Sudan (ep) 
b. Pregnant + mortality + Africa 
c. Pregnant + mortality + Sudan 
d. Sudan 
2. Anaemia + malaria + Sudan 
3. Anaemia + malaria + Africa 
4. Cerebral malaria + Sudan. 
5. Cerebral malaria.  
6. Severe malaria + Sudan.  
7. Measles + 
a. Epidemiology + Sudan 
b. Epidemiology + Africa 
8. Diabetes mellitus +  
a. Africa  
b. Africa + age distribution. 
c. Complications 
d. Prevalence Africa 
e. Prevalence Saudi Arabia. 
f. Neuropathy. 
g. Neuropathy frequency. 
h. Diabetic foot and peripheral vascular disease. 
9. Low birth weight + 
a. Sudan 
 annex B: Keywords used in the search of electronic databases 
 129
b. Traditional birth attendants. 
c. Unskilled birth attendants. 
d. Perinatal mortality + traditional birth attendants + Sudan. 
e. Cerebral palsy + low birth weight. 
10. Anaemia + hemorrhage + Sudan 
11. Anaemia + hemorrhage + Africa. 
12. Anaemia + pregnancy + Sudan 
13. Antepartum + postpartum + hemorrhage  
14. Antepartum + postpartum + hemorrhage + complications. 
15. Complications + maternal hemorrhage. 
16. Death + hemorrhage+ Sudan. 
17. Incidence + Postpartum hemorrhage 
18. Maternal hemorrhage + Sudan 
19. Maternal mortality + causes + Sudan 
20. Maternal mortality + Sudan. 
21. Maternal age + mortality 
22. Age + maternal mortality + Africa 
23. Severe postpartum anaemia + Africa 
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ANNEX C: LIST OF LOCATIONS OF DATA SEARCH 
1. Health research institutes: 
a. National health laboratory. 
b. Tropical medicine research institutes 
c. Institute of endemic diseases. 
d. Blue Nile research institute 
e. Diabetes and endocrine diseases research centre.  
2. Ministry of Health directorates and programs: 
a. Expanded programme of immunization 
b. Malaria control directorate. 
c. Epidemiology directorate. 
d. Non communicable diseases administration, PHC directorate. 
e. Reproductive health directorate. 
f. National health information center. 
g. Planning directorate, research unit. 
3. Non-governmental organizations: 
a. Plan sudan 
b. Okenden International. 
c. UNICEF (United Nations Children Fund) 
d. Care 
e. Goal 
f. MSF (Medecin Sans Frontieres France)  
g. SCF (S) UK 
h. MEDAIR 
i. IRC (International Rescue Committee) 
j. ACF (Action Contre la Faim) 
k. Accord 
l. Islamic Relief Worldwide 
 
   4. Faculty of Medicine – University of Khartoum: 
a. Department of Obstetrics and Gynaecology 
b. Departdment of Paediatrics and Child health 
 annex D: Tools of data collection 
 131
ANNEX D: TOOLS OF DATA COLLECTION 
STUDY SUMMARY SHEET 
Identification:  
1) Disease: ................................................ 
2) Study number: .................................... 
3) Title: ...................................................... 
4) Author: ................................................. 
5) Source: .................................................. 
Study eligibility:   
1) Study design:  a. Community based                   b. Not community based  
2) Study area: ....................................................................................................................  
3) Year of study: ...........................................   
4) Epidemiological estimates provided:  
a. Incidence rate 
b. Prevalence rate 
c. Remission proportion 
d. Case fatality ratio 
e. Average duration 
f. Mortality rate 
g. age distribution of cases or deaths 
h. sex distribution of cases or deaths  
i. disability proportions 
j. Others……………………   
 
Case definition: 
................................................................................................................................................ 
................................................................................................................................................ 
................................................................................................................................................ 
Study population description: 
................................................................................................................................................ 
................................................................................................................................................ 
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Quality: 
1) Study design:  
a. case study  
b. cross – sectional   
 
c. cohort    
d. case – control  
e. experimental 
 
2) Sample size: ………………. 
a. adequate  b. inadequate   c. unspecified 
3) Sampling technique:  
a. representative   b. not representative     c. unspecified 
4) Data quality assurance:  
a. adequate   b. Inadequate   c. unspecified 
5) Missing data and dropouts: ...................................................................... 
6) Statistical analysis 
a. adequate   b. inadequate   c. unspecified 
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Results: 
Incidence  Prevalence  Remission Case 
fatality 
Duration  Age 
groups 
M F T M F T  M F T M F T  M F T  
                
                
                
                
Total                 
 
Disability  Mortality  
     
Age 
groups 
M F  T  M F T  M F T M F T
 
M F T  M F T 
                   
                   
                   
Total                    
 
Other estimates:  
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 DATA COLLECTION CHECKLIST 
Disease ............................................................................................................................... 
Study eligibility: 
1. Study design:  a. Population based  b. Not Population based 
2. Study area ......................................................................................................  
3. Year of study ................................................................................................  
4. Epidemiological estimates provided (at least one): 
a. incidence rate   b. prevalence 
c. remission proportion  d. case fatality ratio 
e. average duration   f. mortality rate 
g. age distribution of cases or deaths 
h. sex distribution of cases or deaths 
i. disability proportions  j. others  
Publication status: 
a. Published  b. In process for publication 
c. Unpublished  
If unpublished or in process for publication, consent obtained: 
a. Yes   b. No  
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ANNEX E: CONSENT 
Federal Ministry of Health 
In collaboration with the Department of Community Medicine 
Faculty of Medicine 
University of Khartoum 
The Burden of Diseases and Injuries in Sudan in 2002 
 
Principal investigator for Phase 1: Dr. Safa Ibrahim Abdelaziz 
Department of Community Medicine 
Faculty of medicine 
University of Khartoum 
 
The purpose of this study is to measure the burden in terms of Disability Adjusted Life 
Years of a comprehensive list of diseases and injuries in Sudan in 2002. This is a new 
approach that summarizes information on mortality and morbidity caused by these 
conditions. The study will provide summarized and comprehensive information needed 
for planning and priority setting, and thus facilitate evidence based health policy.  
The study will be conducted in the form of a project of two phases. Phase 1 is a pilot 
study to pretest the approach in Sudan’s data settings. It will assess the burden of 14 
selected conditions: Malaria, Shistosomiasis, Meningitis, Measles, Tuberculosis, 
HIV/AIDS, maternal haemorrhage, protein energy malnutrition, diarrhoeal diseases, 
Acute respirator tract infections, low birth weight, Diabetes mellitus, Hypertension and 
road traffic accidents. 
Phase 2 will use information provided in Phase 1 to assess the burden of the remaining 
conditions consisting of communicable and non – communicable diseases and injuries. 
The study will rely on secondary data from published and unpublished reports, studies, 
and raw data related to the conditions under study. 
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We shall be very thankful if you provide us with the unpublished data and information 
available to you. In our part we guarantee the following: 
o The data/information will be used for the stated purpose only. 
o The data/information will not be used for any other purpose. Should this 
become necessary, a separate consent will be requested. 
o No further processing of the data/information will be done after the end of 
the study. Should this become necessary, a new separate consent will be 
obtained. 
o The data/information will not be shared with any third party without the 
knowledge and consent of the owner. 
o Access to the data/information will be restricted to the researchers. 
 
 
 
Principal investigator 
Burden of Disease Project 
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Consent 
• I have been approached to provide unpublished data/information for the purpose 
of studying the burden of diseases and injuries in Sudan in 2002. 
• I have been informed and fully understand the purposes and nature of the study. 
• I understand that the researchers guarantee the following: 
o The data/information will be used for the stated purpose only. 
o The data/information will not be used for any other purpose. Should this 
become necessary, a separate consent will be requested. 
o No further processing of the data/information will be done after the end of 
the study. Should this become necessary, a new separate consent will be 
obtained. 
o The data/information will not be shared with any third party without the 
knowledge and consent of the owner. 
o Access to the data/information will be restricted to the researchers. 
I therefore agree to provide the data/information about: 
......................................................................................................................................  
......................................................................................................................................  
In hard form / soft form 
.........................................................................................................  
Name..............................................................................................   
Status ..............................................................................................  
Signature .......................................................................................Date: .............................  
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ANNEX F: EXPERT PANEL MEMBERS 
1. Professor Salah Ahmed Ibrahim 
Department of Paediatrics and Child Health – Faculty of Medicine – University of 
Khartoum.  
2. Professor Zein Alabideen Mohammed Ahmed 
Department of Paediatrics and Child Health – Faculty of Medicine – University of 
Khartoum.  
3. Professor Abdel Salam Gereis 
Department of Obstetrics and Gynaecology – Faculty of Medicine – University of 
Khartoum.  
4. Professor Almahdi Mohamed Ali 
Department of Internal Medicine  – Faculty of Medicine – University of 
Khartoum.  
5. Dr. Alfatih Malik 
National Coordinator – National Malaria Control Administration – Federal 
Ministry of Health. 
6. Dr. Abdelrahim Mohamed Ahmed 
Senior orthopaedic surgeon 
 
 
 
